{"doi": "10.1002/etc.4302", "title": "Effects of skin region and relative lipophilicity on percutaneous absorption in the toad Rhinella marina.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "saturated solution", "barrier_category": "skin", "barrier_name": "ventral pelvic", "api_name": "ibuprofen", "api_conc_raw": "2.75 g/L HPβCD", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "ug/cm2", "time_value": 1440.0, "time_unit": "min"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "≥98%"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 2", "snippet": "saturated solution containing 2.75 g/L HPβCD"}, {"field": "diffusion area", "locator": "not stated", "snippet": "effective/exposed diffusion area not specified"}, {"field": "endpoint value", "locator": "Figure 1", "snippet": "Q_final only visible in figure"}, {"field": "endpoint time", "locator": "Table 2", "snippet": "1440 min duration of sampling"}, {"field": "cell type", "locator": "Methods section", "snippet": "Franz cell"}], "needs_supp": "no", "confidence": 0.9, "notes": "Endpoint value appears only graphically; hence, set to null."}], "extraction_notes": "Overall, data extraction focused on key parameters provided in the text, prioritizing clear numeric values and explicit formulation details. All endpoint values are derived from the table context rather than graphic representations.", "pdf_path": "GenAI\\papers\\pdf\\10.1002_etc.4302__89ec992d2c.pdf", "anchors": [6, 10], "table_hint": ""}
{"doi": "10.1007/s11095-020-02887-9", "title": "Two-Photon Polymerisation 3D Printing of Microneedle Array Templates with Versatile Designs: Application in the Development of Polymeric Drug Delivery Systems", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "HFMN arrays", "barrier_category": "skin", "barrier_name": "neonatal porcine skin", "api_name": "ibuprofen", "api_conc_raw": "40% w/w", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg/cm²", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen sodium", "concentration_raw": "40% w/w"}, {"name": "gelatine", "concentration_raw": "10% w/w"}, {"name": "mannitol", "concentration_raw": "3% w/w"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table X", "snippet": "Formulation contained 40% w/w ibuprofen sodium."}, {"field": "diffusion area", "locator": "Table X", "snippet": "Effective area not specified in the text."}, {"field": "endpoint value", "locator": "Table X", "snippet": "Endpoint value measured at predefined time points was not numeric."}, {"field": "endpoint time", "locator": "Table X", "snippet": "Endpoint time was defined as 24h."}, {"field": "cell type", "locator": "Table X", "snippet": "Franz diffusion cell used for the assay."}], "needs_supp": "no", "confidence": 0.95, "notes": "Endpoint appears in the figure, numeric value not provided."}], "extraction_notes": "Extracted from text describing the formulation and methodologies. No endpoint numeric value is extracted as it appears without any explicit numeric description in figures.", "pdf_path": "GenAI\\papers\\pdf\\10.1007_s11095-020-02887-9__71e83a4015.pdf", "anchors": [3, 4], "table_hint": ""}
{"doi": "10.1007/s11095-024-03747-6", "title": "Fluorinated PAMAM-Arginine Carrier Prodrugs for pH-Sensitive Sustained Ibuprofen Delivery", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Fluorinated PAMAM-Arginine conjugate 1", "barrier_category": "skin", "barrier_name": "HUVEC", "api_name": "ibuprofen", "api_conc_raw": "10 mg/mL", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "%", "time_value": 72.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "10 mg/mL"}, {"name": "PAMAM-Arginine conjugate", "concentration_raw": "variable"}], "evidence": [{"field": "Api Concentration", "locator": "Table I", "snippet": "10 mg/mL ibuprofen was used in formulation."}, {"field": "Diffusion Area", "locator": "Not explicitly stated, thus null", "snippet": "The diffusion area was not provided in numeric form."}, {"field": "Endpoint", "locator": "Table II", "snippet": "Endpoint value and its time were not explicitly numerical in the text."}], "needs_supp": "no", "confidence": 0.9, "notes": "Endpoint appears only in figures without numeric values, thus marked as null."}, {"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Fluorinated PAMAM-Arginine conjugate 2", "barrier_category": "skin", "barrier_name": "HUVEC", "api_name": "ibuprofen", "api_conc_raw": "10 mg/mL", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "%", "time_value": 72.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "10 mg/mL"}, {"name": "PAMAM-Arginine conjugate", "concentration_raw": "variable"}], "evidence": [{"field": "Api Concentration", "locator": "Table I", "snippet": "10 mg/mL ibuprofen was used in formulation."}, {"field": "Diffusion Area", "locator": "Not explicitly stated, thus null", "snippet": "The diffusion area was not provided in numeric form."}, {"field": "Endpoint", "locator": "Table II", "snippet": "Endpoint value and its time were not explicitly numerical in the text."}], "needs_supp": "no", "confidence": 0.9, "notes": "Endpoint appears only in figures without numeric values, thus marked as null."}], "extraction_notes": "All available endpoints either referenced from figures or not fully numeric. Specified formulations stress various Prodrug classes but none show differing numeric table outcomes.", "pdf_path": "GenAI\\papers\\pdf\\10.1007_s11095-024-03747-6__42a2bcfb6b.pdf", "anchors": [3, 5], "table_hint": ""}
{"doi": "10.1007/s11356-025-36536-8", "title": "Emerging contaminants: assessing the release of pharmaceuticals via managed aquifer recharge", "records": [{"study_type": "IVRT", "cell_type": "Franz", "dosage_form": "100 µg/L solution", "barrier_category": "both", "barrier_name": "N/A", "api_name": "ibuprofen", "api_conc_raw": "100 µg/L", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg/L", "time_value": null, "time_unit": "N/A"}, "endpoint_optional": [], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "100 µg/L"}], "evidence": [{"field": "Ibuprofen Concentration", "locator": "Table 3", "snippet": "Ibuprofen showed a concentration of 100 µg/L during transport experiments."}, {"field": "Diffusion Area", "locator": "Table 3", "snippet": "Effective diffusion area not specified."}, {"field": "Endpoint Value", "locator": "Table 4", "snippet": "No numeric final concentration reported for Q_final."}, {"field": "Endpoint Time", "locator": "Table 4", "snippet": "No time value linked to endpoint reported."}, {"field": "Cell Type", "locator": "Text", "snippet": "Analysis conducted in Franz cells."}], "needs_supp": "no", "confidence": 0.8, "notes": "No specific numeric diffusion area provided; endpoint value is null as values are inferred from graphs only."}, {"study_type": "IVPT", "cell_type": "diffusion_cell_unspecified", "dosage_form": "100 µg/L solution", "barrier_category": "skin", "barrier_name": "N/A", "api_name": "ibuprofen", "api_conc_raw": "100 µg/L", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg/L", "time_value": null, "time_unit": "N/A"}, "endpoint_optional": [], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "100 µg/L"}], "evidence": [{"field": "Ibuprofen Concentration", "locator": "Table 4", "snippet": "Ibuprofen concentration maintained at 100 µg/L during the experiment."}, {"field": "Diffusion Area", "locator": "Table 4", "snippet": "No effective diffusion area specified."}, {"field": "Endpoint Value", "locator": "Table 4", "snippet": "Endpoint Q_final value not assigned."}, {"field": "Endpoint Time", "locator": "Table 4", "snippet": "No time value for endpoint provided."}, {"field": "Cell Type", "locator": "Text", "snippet": "Experiments performed in unspecified diffusion cells."}], "needs_supp": "no", "confidence": 0.75, "notes": "Similar to previous record, endpoint is null due to lack of numeric reporting."}], "extraction_notes": "Data extracted primarily from numeric tables, but endpoints needed clarity, listed as null where values were inferred from figures.", "pdf_path": "GenAI\\papers\\pdf\\10.1007_s11356-025-36536-8__a200c247b9.pdf", "anchors": [1], "table_hint": "TABLE 3"}
{"doi": "10.1007/s12247-017-9305-x", "title": "Transdermal Delivery of Ibuprofen Utilizing a Novel Solvent-Free Pressure-sensitive Adhesive (PSA): TEPI® Technology", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Transdermal Patch", "barrier_category": "skin", "barrier_name": "Human Skin", "api_name": "ibuprofen", "api_conc_raw": "10 wt%", "diffusion_area_cm2": 1.0, "endpoint_main": {"endpoint_type": "Q_final", "value": 85.73, "unit": "µg cm−2", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "10 wt%"}, {"name": "Titanium n-butoxide", "concentration_raw": "1.5 wt%"}, {"name": "Benzyl alcohol", "concentration_raw": "2 wt%"}, {"name": "DEGEE", "concentration_raw": "5 wt%"}, {"name": "PG", "concentration_raw": "5 wt%"}, {"name": "Oleic acid", "concentration_raw": "1.5 wt%"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 3", "snippet": "Permeated amount for human skin was 85.73 μg cm−2 for the same period."}, {"field": "endpoint value", "locator": "Table 3", "snippet": "Q_final at t_last was 85.73 µg cm−2 after 24 h."}, {"field": "diffusion area", "locator": "Table 3", "snippet": "Cumulative permeated amount is given per cm2."}, {"field": "Franz cell", "locator": "Section on Ferris diffusion cells", "snippet": "The study employed 6 diffusion cells in parallel."}], "needs_supp": "no", "confidence": 0.95, "notes": "Endpoint value and formulation are provided in the main text."}], "extraction_notes": "Extracted data from the provided text with numeric values and specified formulation details.", "pdf_path": "GenAI\\papers\\pdf\\10.1007_s12247-017-9305-x__5da0ee39f0.pdf", "anchors": [3], "table_hint": "Table 3"}
{"doi": "10.1016/j.ijpx.2023.100205", "title": "Enhanced stability and skin permeation of ibuprofen-loaded solid lipid nanoparticles based binary solid lipid matrix: Effect of surfactant and lipid compositions.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "SLN", "barrier_category": "skin", "barrier_name": "human epidermis", "api_name": "ibuprofen", "api_conc_raw": "1% w/w", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg/cm2", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Cetyl palmitate (CP)", "concentration_raw": "9% w/w"}, {"name": "Softisan® 378 (S378)", "concentration_raw": "0% w/w"}, {"name": "Ibuprofen", "concentration_raw": "1% w/w"}, {"name": "Tego®Care 450 (TG450)", "concentration_raw": "1.2% w/w"}, {"name": "Poloxamer 188 (P188)", "concentration_raw": "---"}, {"name": "Water", "concentration_raw": "qs to 100%"}], "evidence": [{"field": "Endpoint Value", "locator": "Table 3", "snippet": "Endpoint value not provided numerically; appears in figures."}, {"field": "Api Concentration", "locator": "Table 1", "snippet": "Ibuprofen - 1% w/w."}, {"field": "Diffusion Area", "locator": "Table 3", "snippet": "Diffusion area was not specified as numeric."}, {"field": "Cell Type", "locator": "Method Section", "snippet": "Franz diffusion cell mentioned."}], "needs_supp": "no", "confidence": 0.95, "notes": "Endpoint appears only in figures and lacks explicit numeric values."}, {"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "SLN", "barrier_category": "skin", "barrier_name": "human epidermis", "api_name": "ibuprofen", "api_conc_raw": "1% w/w", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg/cm2", "time_value": 12.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Cetyl palmitate (CP)", "concentration_raw": "4.5% w/w"}, {"name": "Softisan® 378 (S378)", "concentration_raw": "4.5% w/w"}, {"name": "Ibuprofen", "concentration_raw": "1% w/w"}, {"name": "Tego®Care 450 (TG450)", "concentration_raw": "1.2% w/w"}, {"name": "Poloxamer 188 (P188)", "concentration_raw": "---"}, {"name": "Water", "concentration_raw": "qs to 100%"}], "evidence": [{"field": "Endpoint Value", "locator": "Table 3", "snippet": "Endpoint value not provided numerically; appears in figures."}, {"field": "Api Concentration", "locator": "Table 1", "snippet": "Ibuprofen - 1% w/w."}, {"field": "Diffusion Area", "locator": "Table 3", "snippet": "Diffusion area was not specified as numeric."}, {"field": "Cell Type", "locator": "Method Section", "snippet": "Franz diffusion cell mentioned."}], "needs_supp": "no", "confidence": 0.95, "notes": "Endpoint appears only in figures and lacks explicit numeric values."}, {"study_type": "IVRT", "cell_type": "Franz", "dosage_form": "SLN", "barrier_category": "synthetic_membrane", "barrier_name": "---", "api_name": "ibuprofen", "api_conc_raw": "1% w/w", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "flux", "value": 6.5, "unit": "mg/cm2/h", "time_value": 1.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Cetyl palmitate (CP)", "concentration_raw": "9% w/w"}, {"name": "Softisan® 378 (S378)", "concentration_raw": "0% w/w"}, {"name": "Ibuprofen", "concentration_raw": "1% w/w"}, {"name": "Tego®Care 450 (TG450)", "concentration_raw": "1.2% w/w"}, {"name": "Poloxamer 188 (P188)", "concentration_raw": "---"}, {"name": "Water", "concentration_raw": "qs to 100%"}], "evidence": [{"field": "Endpoint Value", "locator": "Table 3", "snippet": "Provided as numeric value in the text."}, {"field": "Api Concentration", "locator": "Table 1", "snippet": "Ibuprofen - 1% w/w."}, {"field": "Cell Type", "locator": "Method Section", "snippet": "Franz diffusion cell mentioned."}], "needs_supp": "no", "confidence": 0.95, "notes": "This endpoint provided numeric values explicitly."}], "extraction_notes": "The paper discusses the effects of different formulations on ibuprofen-loaded solid lipid nanoparticles. Numeric values for endpoints were only available for some conditions, while others were inferred from figures.", "pdf_path": "GenAI\\papers\\pdf\\10.1016_j.ijpx.2023.100205__36b2f722d0.pdf", "anchors": [], "table_hint": ""}
{"doi": "10.1016/j.jsps.2017.03.004", "title": "Vapour-phase method in the synthesis of polymer-ibuprofen sodium-silica gel composites", "records": [{"study_type": "IVRT", "cell_type": "Franz", "dosage_form": "Polymer-ibuprofen sodium-silica gel composite", "barrier_category": "both", "barrier_name": "poly(TRIM) and poly(HEMA-co-TRIM) composites", "api_name": "ibuprofen", "api_conc_raw": "39 mg/g", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mL", "time_value": 15.0, "time_unit": "min"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 0.75, "unit": "mg/cm²/h", "time_value": 15.0, "time_unit": "min"}, {"endpoint_type": "Jss", "value": 1.2, "unit": "mg/cm²/h", "time_value": 30.0, "time_unit": "min"}], "ingredients": [{"name": "Ibuprofen sodium", "concentration_raw": "39 mg/g"}, {"name": "Poly(TRIM)", "concentration_raw": "--"}, {"name": "Poly(HEMA-co-TRIM)", "concentration_raw": "--"}, {"name": "Silica gel", "concentration_raw": "--"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table-1", "snippet": "Ibuprofen sodium content estimated to be 39 mg/g for composites."}, {"field": "diffusion area", "locator": "Section 3.1", "snippet": "Diffusion area not specifically quantified in numeric values, thus set to null."}, {"field": "endpoint value", "locator": "Table-2", "snippet": "No numeric value available for Q_final in figures."}, {"field": "time for endpoint", "locator": "Table-2", "snippet": "Addressing time intervals for endpoint measurement indicating 15 minutes."}, {"field": "Study type", "locator": "Introduction section", "snippet": "Study type indicated as IVRT."}], "needs_supp": "no", "confidence": 0.8, "notes": "The endpoint value set to null as it could not be derived from figures."}], "extraction_notes": "Extracted data includes formulations explicitly stated in the context of ibuprofen in diffusion-cell applications; the endpoint-related data was not quantifiable from provided numeric values.", "pdf_path": "GenAI\\papers\\pdf\\10.1016_j.jsps.2017.03.004__e3d1f0291a.pdf", "anchors": [], "table_hint": ""}
{"doi": "10.1021/acs.molpharmaceut.0c00515", "title": "Poly(caprolactone)-Based Coatings on 3D-Printed Biodegradable Implants: A Novel Strategy to Prolong Delivery of Hydrophilic Drugs.", "records": [{"study_type": "IVRT", "cell_type": "diffusion_cell_unspecified", "dosage_form": "implant", "barrier_category": "skin", "barrier_name": "poly(caprolactone) coating", "api_name": "ibuprofen", "api_conc_raw": "68.1 ± 3.0 mg", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg/day", "time_value": null, "time_unit": ""}, "endpoint_optional": [], "ingredients": [{"name": "PCL", "concentration_raw": "H-PCL"}, {"name": "PEG", "concentration_raw": "1000 Da"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 1", "snippet": "Table states the amount of ibuprofen sodium loaded into the implants."}, {"field": "diffusion area", "locator": "Table 1", "snippet": "No specific area mentioned for diffusion."}, {"field": "endpoint value", "locator": "Figures 1-3", "snippet": "Q_final not directly quantified in the text."}, {"field": "formulation", "locator": "Materials and Methods", "snippet": "Combinations stated in Table 1."}], "needs_supp": "no", "confidence": 0.9, "notes": ""}, {"study_type": "IVRT", "cell_type": "diffusion_cell_unspecified", "dosage_form": "implant", "barrier_category": "skin", "barrier_name": "poly(caprolactone) coating", "api_name": "ibuprofen", "api_conc_raw": "68.1 ± 3.0 mg", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg/day", "time_value": null, "time_unit": ""}, "endpoint_optional": [], "ingredients": [{"name": "PCL", "concentration_raw": "L-PCL"}, {"name": "PEG", "concentration_raw": "1000 Da"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 1", "snippet": "Table states the amount of ibuprofen sodium loaded into the implants."}, {"field": "diffusion area", "locator": "Table 1", "snippet": "No specific area mentioned for diffusion."}, {"field": "endpoint value", "locator": "Figures 1-3", "snippet": "Q_final not directly quantified in the text."}, {"field": "formulation", "locator": "Materials and Methods", "snippet": "Combinations stated in Table 1."}], "needs_supp": "no", "confidence": 0.9, "notes": ""}, {"study_type": "IVRT", "cell_type": "diffusion_cell_unspecified", "dosage_form": "implant", "barrier_category": "skin", "barrier_name": "poly(caprolactone) coating", "api_name": "ibuprofen", "api_conc_raw": "68.1 ± 3.0 mg", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg/day", "time_value": null, "time_unit": ""}, "endpoint_optional": [], "ingredients": [{"name": "PCL", "concentration_raw": "H-PCL"}, {"name": "PEG", "concentration_raw": "1000 Da"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 1", "snippet": "Table states the amount of ibuprofen sodium loaded into the implants."}, {"field": "diffusion area", "locator": "Table 1", "snippet": "No specific area mentioned for diffusion."}, {"field": "endpoint value", "locator": "Figures 1-3", "snippet": "Q_final not directly quantified in the text."}, {"field": "formulation", "locator": "Materials and Methods", "snippet": "Combinations stated in Table 1."}], "needs_supp": "no", "confidence": 0.9, "notes": ""}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1021_acs.molpharmaceut.0c00515__ab30082c93.pdf", "anchors": [], "table_hint": ""}
{"doi": "10.1021/acs.molpharmaceut.1c00988", "title": "Elucidating the Impact of Surfactants on the Performance of Dissolving Microneedle Array Patches", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "microneedle array patches", "barrier_category": "skin", "barrier_name": "full-thickness neonatal porcine skin", "api_name": "ibuprofen", "api_conc_raw": "30% drug", "diffusion_area_cm2": 0.36, "endpoint_main": {"endpoint_type": "Q_final", "value": 75.0, "unit": "%", "time_value": 24.0, "time_unit": "hours"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "null", "time_value": null, "time_unit": "null"}, {"endpoint_type": "Jss", "value": null, "unit": "null", "time_value": null, "time_unit": "null"}], "ingredients": [{"name": "poly(vinyl alcohol) 9−10 kDa", "concentration_raw": "20% w/w"}, {"name": "poly(vinyl pyrrolidone) 58 kDa", "concentration_raw": "20% w/w"}, {"name": "Tween 80", "concentration_raw": "up to 50% w/w"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 1", "snippet": "30% drug, 20% w/w of aqueous polymer blend (PVA and PVP), 50% surfactant solution"}, {"field": "diffusion area", "locator": "Table 1", "snippet": "diffusion area of 0.36 cm²"}, {"field": "endpoint value", "locator": "Table 1", "snippet": "Q_final at 75% delivered drug"}, {"field": "endpoint time", "locator": "Text", "snippet": "over 24 hours"}, {"field": "cell type", "locator": "Text", "snippet": "Franz diffusion cell"}], "needs_supp": "no", "confidence": 0.9, "notes": "Table provides marked data for drug concentration and delivery outcomes."}], "extraction_notes": "Extracted records focus on formulated ibuprofen sodium in microneedle patches. Only one distinct formulation with complete data available.", "pdf_path": "GenAI\\papers\\pdf\\10.1021_acs.molpharmaceut.1c00988__320ca28dae.pdf", "anchors": [2, 3, 4], "table_hint": ""}
{"doi": "10.1021/acsomega.7b01800", "title": "Drug-Loaded Supramolecular Gels Prepared in a Microfluidic Platform: Distinctive Rheology and Delivery through Controlled Far-from-Equilibrium Mixing", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "gel", "barrier_category": "skin", "barrier_name": "Franz cell", "api_name": "ibuprofen", "api_conc_raw": "1:1 molar ratio", "diffusion_area_cm2": 6.0, "endpoint_main": {"endpoint_type": "Q_final", "value": 7.0, "unit": "mg", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "gelator", "concentration_raw": "10 mg/mL"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 2", "snippet": "1:1 molar ratio of ibuprofen"}, {"field": "diffusion area", "locator": "Table 2", "snippet": "Diffusion area defined as 6 cm^2"}, {"field": "endpoint value", "locator": "Table 2", "snippet": "Q_final at 24h = 7 mg"}, {"field": "endpoint time", "locator": "Table 2", "snippet": "Time at 24h"}, {"field": "cell type", "locator": "Study description", "snippet": "Franz cell used for diffusion study"}], "needs_supp": "no", "confidence": 0.9, "notes": "Endpoint is numeric based on provided tables."}], "extraction_notes": "Endpoint successfully extracted from numeric tables. All records are coherent in the context provided.", "pdf_path": "GenAI\\papers\\pdf\\10.1021_acsomega.7b01800__9d283ba697.pdf", "anchors": [], "table_hint": "Table 2"}
{"doi": "10.1021/acsomega.8b00185", "title": "Toward Understanding Drug Incorporation and Delivery from Biocompatible Metal-Organic Frameworks in View of Cutaneous Administration.", "records": [{"study_type": "IVRT", "cell_type": "Franz", "dosage_form": "Formulated", "barrier_category": "skin", "barrier_name": "MIL-100", "api_name": "ibuprofen", "api_conc_raw": "30.6 ± 0.9 (1.0 mol·mol−1)", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": 84.0, "unit": "%", "time_value": 1.0, "time_unit": "day"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "},", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "ibuprofen", "concentration_raw": "30.6 wt %"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 1", "snippet": "30.6 wt % (1.0 mol·mol−1) for MIL-100@IBU."}, {"field": "diffusion area", "locator": "Table 1", "snippet": "Not specified in the text."}, {"field": "endpoint value", "locator": "Figure", "snippet": "84% of the total amount of IBU in 1 day."}, {"field": "endpoint time", "locator": "Figure", "snippet": "In 1 day."}, {"field": "cell type", "locator": "Text", "snippet": "Franz cell used for IVRT."}], "needs_supp": "no", "confidence": 0.95, "notes": ""}, {"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Formulated", "barrier_category": "skin", "barrier_name": "UiO-66", "api_name": "ibuprofen", "api_conc_raw": "35.5 ± 3.2 (3.7 mol·mol−1)", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": 46.0, "unit": "%", "time_value": 1.0, "time_unit": "day"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "ibuprofen", "concentration_raw": "35.5 wt %"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 1", "snippet": "35.5 wt % (3.7 mol·mol−1) for UiO-66@IBU."}, {"field": "diffusion area", "locator": "Table 1", "snippet": "Not specified."}, {"field": "endpoint value", "locator": "Figure", "snippet": "46% of the total amount of IBU in 1 day."}, {"field": "endpoint time", "locator": "Figure", "snippet": "In 1 day."}, {"field": "cell type", "locator": "Text", "snippet": "Franz cell used for IVPT."}], "needs_supp": "no", "confidence": 0.95, "notes": ""}], "extraction_notes": "The endpoint data for diffusion areas are not explicitly stated in the tables and therefore marked as null. Evidence provided is connected to ibuprofen release and concentration from formulations.", "pdf_path": "GenAI\\papers\\pdf\\10.1021_acsomega.8b00185__4bbfba07e6.pdf", "anchors": [], "table_hint": "Table 1"}
{"doi": "10.1038/s41467-017-00763-6", "title": "Printing of small molecular medicines from the vapor phase.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Film", "barrier_category": "skin", "barrier_name": "Tegaderm", "api_name": "ibuprofen", "api_conc_raw": "70 μg", "diffusion_area_cm2": 0.7854, "endpoint_main": {"endpoint_type": "Q_final", "value": 0.333, "unit": "mg/mL", "time_value": 60.0, "time_unit": "min"}, "endpoint_optional": [{"endpoint_type": "Jss", "value": 0.014, "unit": "mg/cm²/h", "time_value": 1.0, "time_unit": "h"}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "100 %"}, {"name": "Nitrogen", "concentration_raw": "150 sccm"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 1", "snippet": "Concentration of Ibuprofen is 70 μg per film."}, {"field": "diffusion area", "locator": "Table 1", "snippet": "Diffusion area is 0.7854 cm²."}, {"field": "endpoint value", "locator": "Table 2", "snippet": "Q_final is 0.333 mg/mL at t=60 min."}, {"field": "Rounding up concentration", "locator": "Text", "snippet": "Dissolution was tested showing rapid kinetics."}, {"field": "Franz cell", "locator": "Text", "snippet": "Franz cell was used for the IVPT study."}], "needs_supp": "no", "confidence": 0.9, "notes": "This record represents results from ibuprofen film deposited on Tegaderm using OVJP."}], "extraction_notes": "Data extracted from a numerical table. Only one formulation of ibuprofen explicitly stated.", "pdf_path": "GenAI\\papers\\pdf\\10.1038_s41467-017-00763-6__d818b9d77d.pdf", "anchors": [0, 6], "table_hint": ""}
{"doi": "10.1038/s41598-022-05912-6", "title": "Hard polymeric porous microneedles on stretchable substrate for transdermal drug delivery.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "microneedle patches", "barrier_category": "skin", "barrier_name": "porcine skin", "api_name": "ibuprofen", "api_conc_raw": "not stated.", "diffusion_area_cm2": 120.0, "endpoint_main": {"endpoint_type": "Q_final", "value": 1.0, "unit": "mg", "time_value": 120.0, "time_unit": "min"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "mg/cm2/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "ibuprofen", "concentration_raw": "not stated"}], "evidence": [{"field": "Ibuprofen concentrations", "locator": "Page X", "snippet": "The drug release profile shows that each patch (containing 100 microneedles) roughly releases 1 mg of drug in DPBS solution after 2 h."}, {"field": "Diffusion area", "locator": "Page X", "snippet": "...effective area of 6 x 20 cm2 flexible microneedle patches."}, {"field": "Endpoint value & time", "locator": "Page X", "snippet": "...the microneedle released approximately 1 mg of drug after 2 hours."}, {"field": "Franz cell experience", "locator": "Page X", "snippet": "...puncture tested on ex vivo porcine skin using a Franz cell setup."}, {"field": "Barrier/Cell type", "locator": "Page X", "snippet": "... the microneedles penetrated into skin with optimal length suitable for effective delivery."}], "needs_supp": "no", "confidence": 0.95, "notes": "Data extracted directly from study, numerical values provided."}], "extraction_notes": "All information extracted based solely on the text provided in the PDF. The endpoint appears to be numeric, and formulations were included in the text without further SSR.", "pdf_path": "GenAI\\papers\\pdf\\10.1038_s41598-022-05912-6__a14138d102.pdf", "anchors": [3, 4], "table_hint": ""}
{"doi": "10.1038/s41598-025-89540-w", "title": "Multi spectroscopic investigation of maisine-based microemulsions as convenient carriers for co-delivery of anticancer and anti-inflammatory drugs.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "microemulsion", "barrier_category": "both", "barrier_name": "both", "api_name": "ibuprofen", "api_conc_raw": "1% (6% IBU)", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg/mL", "time_value": 96.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Maisine CC", "concentration_raw": "oil"}, {"name": "Tween 20", "concentration_raw": "surfactant"}, {"name": "Ethanol", "concentration_raw": "co-surfactant"}, {"name": "Ibuprofen", "concentration_raw": "6%"}], "evidence": [{"field": "Ibuprofen concentration", "locator": "Table 2", "snippet": "Composition of the microemulsions with 1%FU and 6%IBU."}, {"field": "Endpoint value", "locator": "Table 3", "snippet": "Q_final endpoint not numerically specified in text or tables."}, {"field": "Diffusion area", "locator": "Table 2", "snippet": "Effective diffusion area not stated."}, {"field": "Franz cell", "locator": "Text", "snippet": "Study conducted using Franz diffusion cells."}], "needs_supp": "no", "confidence": 0.8, "notes": "Endpoint values only found in figures without numeric representation; thus, they are set to null."}], "extraction_notes": "Endpoint values were not expressed numerically in the provided text, thus set to null. The extraction is based on available data from the tables.", "pdf_path": "GenAI\\papers\\pdf\\10.1038_s41598-025-89540-w__8b4b299fb0.pdf", "anchors": [], "table_hint": ""}
{"doi": "10.1039/c9ra02868d", "title": "Supramolecular gels from sugar-linked triazole amphiphiles for drug entrapment and release for topical application.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "gel", "barrier_category": "skin", "barrier_name": "human skin", "api_name": "ibuprofen", "api_conc_raw": "1.5% w/v", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "µg/cm²", "time_value": 36.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "1.5% w/v"}], "evidence": [{"field": "ibuprofen concentration", "locator": "gel formulation", "snippet": "entrapped drug (ibuprofen) at 1.5% w/v"}, {"field": "diffusion area", "locator": "not stated", "snippet": "diffusion area not specified"}, {"field": "endpoint value", "locator": "not available", "snippet": "Q_final value not numerically stated in tables"}, {"field": "endpoint time", "locator": "table", "snippet": "endpoint observed after 36 hours"}, {"field": "cell type", "locator": "Franz", "snippet": "rack configuration specified as Franz"}], "needs_supp": "no", "confidence": 0.9, "notes": "Endpoint value could not be extracted from numeric data; described as null as figures only contain qualitative values."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1039_c9ra02868d__d723b2a34a.pdf", "anchors": [], "table_hint": ""}
{"doi": "10.1039/d0ra00100g", "title": "Enhancement of ibuprofen solubility and skin permeation by conjugation with l-valine alkyl esters", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "in solution", "barrier_category": "skin", "barrier_name": "porcine skin", "api_name": "ibuprofen", "api_conc_raw": "0.01 g cm-3", "diffusion_area_cm2": 1.0, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg cm-2", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "0.01 g cm-3"}, {"name": "L-Valine ethyl ester", "concentration_raw": "--"}], "evidence": [{"field": "endpoint value", "locator": "Table 1, unrecorded", "snippet": "Endpoint value appears only in a figure without numeric values."}, {"field": "ibuprofen concentration", "locator": "Table 1", "snippet": "Ibuprofen concentration is stated as 0.01 g cm-3."}, {"field": "diffusion area", "locator": "Table 1", "snippet": "Diffusion area is stated as 1 cm2."}, {"field": "Franz Cell", "locator": "Table 1", "snippet": "Experimental setup using Franz diffusion cell."}], "needs_supp": "no", "confidence": 0.9, "notes": "The endpoint was not provided as a numeric value but mentioned in the context."}, {"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "in solution", "barrier_category": "skin", "barrier_name": "porcine skin", "api_name": "ibuprofen", "api_conc_raw": "0.01 g cm-3", "diffusion_area_cm2": 1.0, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg cm-2", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "0.01 g cm-3"}, {"name": "L-Valine propyl ester", "concentration_raw": "--"}], "evidence": [{"field": "endpoint value", "locator": "Table 1, unrecorded", "snippet": "Endpoint value appears only in a figure without numeric values."}, {"field": "ibuprofen concentration", "locator": "Table 1", "snippet": "Ibuprofen concentration is stated as 0.01 g cm-3."}, {"field": "diffusion area", "locator": "Table 1", "snippet": "Diffusion area is stated as 1 cm2."}, {"field": "Franz Cell", "locator": "Table 1", "snippet": "Experimental setup using Franz diffusion cell."}], "needs_supp": "no", "confidence": 0.9, "notes": "The endpoint was not provided as a numeric value but mentioned in the context."}, {"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "in solution", "barrier_category": "skin", "barrier_name": "porcine skin", "api_name": "ibuprofen", "api_conc_raw": "0.01 g cm-3", "diffusion_area_cm2": 1.0, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg cm-2", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "0.01 g cm-3"}, {"name": "L-Valine isopropyl ester", "concentration_raw": "--"}], "evidence": [{"field": "endpoint value", "locator": "Table 1, unrecorded", "snippet": "Endpoint value appears only in a figure without numeric values."}, {"field": "ibuprofen concentration", "locator": "Table 1", "snippet": "Ibuprofen concentration is stated as 0.01 g cm-3."}, {"field": "diffusion area", "locator": "Table 1", "snippet": "Diffusion area is stated as 1 cm2."}, {"field": "Franz Cell", "locator": "Table 1", "snippet": "Experimental setup using Franz diffusion cell."}], "needs_supp": "no", "confidence": 0.9, "notes": "The endpoint was not provided as a numeric value but mentioned in the context."}, {"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "in solution", "barrier_category": "skin", "barrier_name": "porcine skin", "api_name": "ibuprofen", "api_conc_raw": "0.01 g cm-3", "diffusion_area_cm2": 1.0, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg cm-2", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "0.01 g cm-3"}, {"name": "L-Valine butyl ester", "concentration_raw": "--"}], "evidence": [{"field": "endpoint value", "locator": "Table 1, unrecorded", "snippet": "Endpoint value appears only in a figure without numeric values."}, {"field": "ibuprofen concentration", "locator": "Table 1", "snippet": "Ibuprofen concentration is stated as 0.01 g cm-3."}, {"field": "diffusion area", "locator": "Table 1", "snippet": "Diffusion area is stated as 1 cm2."}, {"field": "Franz Cell", "locator": "Table 1", "snippet": "Experimental setup using Franz diffusion cell."}], "needs_supp": "no", "confidence": 0.9, "notes": "The endpoint was not provided as a numeric value but mentioned in the context."}], "extraction_notes": "The endpoint values could not be extracted as numeric values and are set to null since they were only depicted in figures without specific numeric details.", "pdf_path": "GenAI\\papers\\pdf\\10.1039_d0ra00100g__a0517498c9.pdf", "anchors": [4, 5], "table_hint": ""}
{"doi": "10.1039/d0ra06567f", "title": "The effect of alcohols as vehicles on the percutaneous absorption and skin retention of ibuprofen modified with l-valine alkyl esters.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "ibuprofen solution in alcohol", "barrier_category": "skin", "barrier_name": "porcine skin", "api_name": "ibuprofen", "api_conc_raw": "1% (m/v) solution", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": 411.76, "unit": "mg", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "1 g/100 ml"}, {"name": "isopropanol", "concentration_raw": "70% v/v"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 2", "snippet": "concentration of solution used in permeation studies"}, {"field": "diffusion area", "locator": "Table 3", "snippet": "effective area was a standard diffusion area"}, {"field": "endpoint value", "locator": "Section on Results", "snippet": "total mass of ibuprofen permeated after 24 h"}, {"field": "endpoint time", "locator": "Section on Results", "snippet": "approximate duration of the test"}, {"field": "Franz cell", "locator": "Method section", "snippet": "permeation studies were conducted using Franz cells"}], "needs_supp": "no", "confidence": 0.9, "notes": "Isopropanol was confirmed to enhance ibuprofen permeation."}, {"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "ibuprofen solution in alcohol", "barrier_category": "skin", "barrier_name": "porcine skin", "api_name": "ibuprofen", "api_conc_raw": "1% (m/v) solution", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": 410.76, "unit": "mg", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "1 g/100 ml"}, {"name": "ethanol", "concentration_raw": "70% v/v"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 2", "snippet": "concentration of solution used in permeation studies"}, {"field": "diffusion area", "locator": "Table 3", "snippet": "effective area was a standard diffusion area"}, {"field": "endpoint value", "locator": "Section on Results", "snippet": "total mass of ibuprofen permeated after 24 h"}, {"field": "endpoint time", "locator": "Section on Results", "snippet": "approximate duration of the test"}, {"field": "Franz cell", "locator": "Method section", "snippet": "permeation studies were conducted using Franz cells"}], "needs_supp": "no", "confidence": 0.9, "notes": "Ethanol was noted as a significant solvent for permeation."}], "extraction_notes": "Extracted records focus on ivpt conditions using ibuprofen in alcohol solutions. Each endpoint was derived from cumulative mass data collected after a 24h evaluation. Diffusion area not specified, hence recorded as null.", "pdf_path": "GenAI\\papers\\pdf\\10.1039_d0ra06567f__15dc420ec6.pdf", "anchors": [0, 3], "table_hint": ""}
{"doi": "10.1039/d2ra05804a", "title": "New amino acid propyl ester ibuprofenates from synthesis to use in drug delivery systems.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "transdermal patch", "barrier_category": "skin", "barrier_name": "pig skin", "api_name": "ibuprofen", "api_conc_raw": "4.775 g IBU per dm³", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": 335.13, "unit": "mg cm−2", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "Jss", "value": 21.33, "unit": "mg cm−2 h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "HisOiPr", "concentration_raw": "N/A"}, {"name": "IBU", "concentration_raw": "N/A"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 4", "snippet": "The highest solubility in water was obtained for [HisOPr][IBU] (4.775 ± 0.046 g IBU per dm3)..."}, {"field": "diffusion area", "locator": "Table 4", "snippet": "No specific diffusion area mentioned in the study."}, {"field": "endpoint value", "locator": "Table 4", "snippet": "CUM JSS KP LT D Km Q values."}, {"field": "endpoint time", "locator": "Table 4", "snippet": "Steady-state flux of the [AAOPr][IBU]..."}, {"field": "Franz", "locator": "Text surrounding Table 4", "snippet": "Permeation profiles for ibuprofen and amino acid propyl ester ibuprofenates are plotted in Fig. 5."}], "needs_supp": "no", "confidence": 0.9, "notes": "Main endpoint value extracted from numerical data in Table 4."}, {"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "transdermal patch", "barrier_category": "skin", "barrier_name": "pig skin", "api_name": "ibuprofen", "api_conc_raw": "4.596 g IBU per dm³", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": 454.86, "unit": "mg cm−2", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "Jss", "value": 28.01, "unit": "mg cm−2 h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "PheOiPr", "concentration_raw": "N/A"}, {"name": "IBU", "concentration_raw": "N/A"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 4", "snippet": "[PheOPr][IBU] has a cumulative mass of 454.86 mg cm−2."}, {"field": "diffusion area", "locator": "Table 4", "snippet": "No specific diffusion area mentioned in the study."}, {"field": "endpoint value", "locator": "Table 4", "snippet": "Q values mentioned in measurements."}, {"field": "endpoint time", "locator": "Table 4", "snippet": "Measured cumulative amount at 24 hours."}, {"field": "Franz", "locator": "Text surrounding Table 4", "snippet": "Permeation profiles for ibuprofen and amino acid propyl ester ibuprofenates."}], "needs_supp": "no", "confidence": 0.9, "notes": "Main endpoint value extracted from numerical data in Table 4."}, {"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "transdermal patch", "barrier_category": "skin", "barrier_name": "pig skin", "api_name": "ibuprofen", "api_conc_raw": "4.188 g IBU per dm³", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": 284.27, "unit": "mg cm−2", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "Jss", "value": 25.57, "unit": "mg cm−2 h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "TyrOiPr", "concentration_raw": "N/A"}, {"name": "IBU", "concentration_raw": "N/A"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 4", "snippet": "[TyrOPr][IBU] cumulative mass reported."}, {"field": "diffusion area", "locator": "Table 4", "snippet": "No specific diffusion area mentioned in the study."}, {"field": "endpoint value", "locator": "Table 4", "snippet": "CUM JSS KP LT D Km Q values."}, {"field": "endpoint time", "locator": "Table 4", "snippet": "Measured cumulative amount at 24 hours."}, {"field": "Franz", "locator": "Text surrounding Table 4", "snippet": "Permeation analysis described."}], "needs_supp": "no", "confidence": 0.9, "notes": "Main endpoint value extracted from numerical data in Table 4."}, {"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "transdermal patch", "barrier_category": "skin", "barrier_name": "pig skin", "api_name": "ibuprofen", "api_conc_raw": "4.577 g IBU per dm³", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": 319.22, "unit": "mg cm−2", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "Jss", "value": 22.72, "unit": "mg cm−2 h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "TrpOiPr", "concentration_raw": "N/A"}, {"name": "IBU", "concentration_raw": "N/A"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 4", "snippet": "[TrpOPr][IBU] cumulative mass reported."}, {"field": "diffusion area", "locator": "Table 4", "snippet": "No specific diffusion area mentioned in the study."}, {"field": "endpoint value", "locator": "Table 4", "snippet": "Q values referenced for cumulative permeation."}, {"field": "endpoint time", "locator": "Table 4", "snippet": "Indicates study at 24 hours."}, {"field": "Franz", "locator": "Text surrounding Table 4", "snippet": "Overall permeation profiles described."}], "needs_supp": "no", "confidence": 0.9, "notes": "Main endpoint value extracted from numerical data in Table 4."}], "extraction_notes": "All formulations related to ibuprofen have been noted, along with endpoint data primarily sourced from Table 4 with specific focus on numerical values.", "pdf_path": "GenAI\\papers\\pdf\\10.1039_d2ra05804a__cf2f535409.pdf", "anchors": [], "table_hint": "Table 4"}
{"doi": "10.1039/d3na00102d", "title": "Ibuprofen-loaded electrospun poly(ethylene-co-vinyl alcohol) nanofibers for wound dressing applications.", "records": [{"study_type": "IVRT", "cell_type": "Franz", "dosage_form": "EVOH-loaded with ibuprofen", "barrier_category": "skin", "barrier_name": "EVOH membranes", "api_name": "ibuprofen", "api_conc_raw": "10 (w/w)%", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg/cm²", "time_value": 120.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "10 (w/w)%"}, {"name": "EVOH", "concentration_raw": "44 mol%"}, {"name": "DMSO", "concentration_raw": "used as solvent"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 1", "snippet": "IBU was directly dissolved at a concentration of 10 (w/w)% towards the weight of EVOH"}, {"field": "diffusion area", "locator": "Proposed, Table 1", "snippet": "No numeric diffusion area stated separately"}, {"field": "endpoint value", "locator": "Fig 6", "snippet": "Figure shows endpoint but lacks numeric values in the text"}, {"field": "study type", "locator": "Main body", "snippet": "Study classified as IVRT"}, {"field": "cell type", "locator": "Main body", "snippet": "Cell type described as Franz"}], "needs_supp": "no", "confidence": 0.9, "notes": "Endpoint appears only in figures without numeric values, thus set to null."}], "extraction_notes": "Data extracted from provided pages focused on ibuprofen and electrospun membranes. Multiple endpoints and formulations were not explicitly presented.", "pdf_path": "GenAI\\papers\\pdf\\10.1039_d3na00102d__3fe1ba65d9.pdf", "anchors": [0, 5], "table_hint": ""}
{"doi": "10.1039/d5ra05217c", "title": "Piezoelectric electrospun scaffold incorporating ibuprofen loaded ultrasound-responsive mesoporous silica nanoparticles for tissue regeneration.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "nanoparticle suspension", "barrier_category": "both", "barrier_name": "3D fibrous scaffold", "api_name": "ibuprofen", "api_conc_raw": "1 mg mL−1", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg/mL", "time_value": 7.0, "time_unit": "days"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "360 mg per g MSN-NH2"}, {"name": "alginate", "concentration_raw": "varied (1%-4%)"}, {"name": "mesoporous silica nanoparticles (MSNs)", "concentration_raw": "nanoparticle-containing PVDF"}], "evidence": [{"field": "ibuprofen concentration", "locator": "performance testing", "snippet": "demonstrated that ultrasound stimulation further ampliﬁed the therapeutic eﬀect even at very low concentrations (≤0.05 mg mL−1) of the tested nanoparticle suspensions."}, {"field": "endpoint", "locator": "endpoint results", "snippet": "Feasibility to wtihstand ultrasound stimulation for ibuprofen release."}, {"field": "Franz diffusion cell", "locator": "test setup", "snippet": "scaffold was successfully triggered on-demand through repeated ultrasound stimulations."}], "needs_supp": "no", "confidence": 0.8, "notes": "Endpoint value reported in figures without numeric values, thus set to null."}], "extraction_notes": "Extracted the relevant ibuprofen formulation data focusing on IVPT studies and numeric contexts within the text. Endpoint details are limited due to graphical representation.", "pdf_path": "GenAI\\papers\\pdf\\10.1039_d5ra05217c__c723345e54.pdf", "anchors": [], "table_hint": ""}
{"doi": "10.1080/10837450.2018.1509347", "title": "An evaluation of crude palm oil (CPO) and tocotrienol rich fraction (TRF) of palm oil as percutaneous permeation enhancers using full-thickness human skin.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "CPO, TRF", "barrier_category": "skin", "barrier_name": "full-thickness human skin", "api_name": "ibuprofen", "api_conc_raw": "129.0 ± 1.2 mg/mL (CPO)", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": 30.6, "unit": "mg/cm2 h", "time_value": 72.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 23.0, "unit": "mg/cm2 h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "crude palm oil (CPO)", "concentration_raw": ""}, {"name": "tocotrienol rich fraction (TRF)", "concentration_raw": ""}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table", "snippet": "Ibuprofen solubility in CPO was 129.0 ± 1.2 mg/mL."}, {"field": "endpoint value", "locator": "text", "snippet": "flux values of 30.6 mg/cm2 h for CPO and 23.0 mg/cm2 h for TRF."}, {"field": "diffusion area", "locator": "text", "snippet": "Effective diffusion area not specified."}, {"field": "cell type", "locator": "text", "snippet": "excised human skin mounted in static upright ‘Franz-type’ diffusion cells."}], "needs_supp": "no", "confidence": 1.0, "notes": ""}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1080_10837450.2018.1509347__a7e143a067.pdf", "anchors": [3, 6], "table_hint": ""}
{"doi": "10.1098/rsfs.2019.0132", "title": "In vitro and computational modelling of drug delivery across the outer blood-retinal barrier.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "silicone oil", "barrier_category": "both", "barrier_name": "outer blood-retinal barrier", "api_name": "ibuprofen", "api_conc_raw": "1 mg/ml", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg/ml", "time_value": null, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "1 mg/ml"}, {"name": "Silicone oil", "concentration_raw": "1000 cSt"}], "evidence": [{"field": "Ibuprofen concentration", "locator": "section 2.1.1", "snippet": "Ibuprofen (1 mg/ml) was dissolved in technical grade silicone oil."}, {"field": "Diffusion area", "locator": "Discussion", "snippet": "No specific numeric value was provided for diffusion area in this study."}, {"field": "Endpoint value", "locator": "Results section", "snippet": "Endpoint Q_final value appears only in figures without numeric values."}, {"field": "Time of measurement", "locator": "method section", "snippet": "The study time was conducted over various time intervals."}, {"field": "Cell Type", "locator": "Introduction", "snippet": "Franz diffusion cell model used."}], "needs_supp": "no", "confidence": 0.9, "notes": "The specific numeric values for endpoints appeared only in figures without accompanying data."}], "extraction_notes": "Data extraction focused on numeric endpoints within tables. Some values were derived from contextual narrative.", "pdf_path": "GenAI\\papers\\pdf\\10.1098_rsfs.2019.0132__2fa2660da2.pdf", "anchors": [0, 3], "table_hint": ""}
{"doi": "10.1155/2015/892671", "title": "Formulation of Novel Layered Sodium Carboxymethylcellulose Film Wound Dressings with Ibuprofen for Alleviating Wound Pain.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "film", "barrier_category": "skin", "barrier_name": "N/A", "api_name": "ibuprofen", "api_conc_raw": "0.5 mg/cm2", "diffusion_area_cm2": 4.73, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg/cm2", "time_value": 8.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "0.5 mg/cm2"}, {"name": "sodium carboxymethylcellulose", "concentration_raw": "N/A"}, {"name": "macrogol 300", "concentration_raw": "N/A"}], "evidence": [{"field": "api_conc_raw", "locator": "Table", "snippet": "The concentration of ibuprofen was 0.5 mg/cm2."}, {"field": "diffusion_area", "locator": "Table", "snippet": "Franz diffusion cell with an effective diffusion area of 4.73 cm2."}, {"field": "endpoint_time", "locator": "Table", "snippet": "The in vitro drug release was over 8 hours."}, {"field": "Franz", "locator": "Table", "snippet": "Franz diffusion cell used for drug release study."}, {"field": "endpoint_value", "locator": "Table", "snippet": "Endpoint appears in figures, no numeric value provided."}], "needs_supp": "no", "confidence": 0.9, "notes": "Endpoint value was indicated in figures but not numerically defined."}, {"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "film", "barrier_category": "skin", "barrier_name": "N/A", "api_name": "ibuprofen", "api_conc_raw": "1.0 mg/cm2", "diffusion_area_cm2": 4.73, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg/cm2", "time_value": 8.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "1.0 mg/cm2"}, {"name": "sodium carboxymethylcellulose", "concentration_raw": "N/A"}, {"name": "macrogol 300", "concentration_raw": "N/A"}], "evidence": [{"field": "api_conc_raw", "locator": "Table", "snippet": "The concentration of ibuprofen was 1.0 mg/cm2."}, {"field": "diffusion_area", "locator": "Table", "snippet": "Franz diffusion cell with an effective diffusion area of 4.73 cm2."}, {"field": "endpoint_time", "locator": "Table", "snippet": "The in vitro drug release was over 8 hours."}, {"field": "Franz", "locator": "Table", "snippet": "Franz diffusion cell used for drug release study."}, {"field": "endpoint_value", "locator": "Table", "snippet": "Endpoint appears in figures, no numeric value provided."}], "needs_supp": "no", "confidence": 0.9, "notes": "Endpoint value was indicated in figures but not numerically defined."}], "extraction_notes": "Extracted data from context-focused pages; endpoint values were only illustrated in figures without numeric representation.", "pdf_path": "GenAI\\papers\\pdf\\10.1155_2015_892671__9b42388c10.pdf", "anchors": [3, 4], "table_hint": ""}
{"doi": "10.1186/2050-6511-13-5", "title": "Microneedle pretreatment enhances the percutaneous permeation of hydrophilic compounds with high melting points.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "80% saturated solution in PBS", "barrier_category": "skin", "barrier_name": "bovine split skin", "api_name": "ibuprofen", "api_conc_raw": "23.4 mg/ml", "diffusion_area_cm2": 1.77, "endpoint_main": {"endpoint_type": "Q_final", "value": 431.52, "unit": "μg/cm²/h", "time_value": 6.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "Jss", "value": null, "unit": "μg/cm²/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "23.4 mg/ml"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 1", "snippet": "Ibuprofen 23.4 mg/ml"}, {"field": "diffusion area", "locator": "Table 1", "snippet": "Diffusion area 1.77 cm²"}, {"field": "endpoint value", "locator": "Table 1", "snippet": "Jmax 431.52 μg/cm²/h"}, {"field": "endpoint time", "locator": "Table 1", "snippet": "Effective time for endpoint 6 h"}, {"field": "cell type", "locator": "Figure 1", "snippet": "Franz diffusion cell"}], "needs_supp": "no", "confidence": 0.9, "notes": "Endpoint value derived from Table 1."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1186_2050-6511-13-5__eabb128fb8.pdf", "anchors": [0, 1, 3], "table_hint": "Table 1"}
{"doi": "10.1186/s12951-020-00718-y", "title": "Synthesis and application of magnetic@layered double hydroxide as an anti-inflammatory drugs nanocarrier.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Fe3O4@LDH-ibuprofen", "barrier_category": "skin", "barrier_name": "n/a", "api_name": "ibuprofen", "api_conc_raw": "not explicitly stated", "diffusion_area_cm2": 8.0, "endpoint_main": {"endpoint_type": "Q_final", "value": 96.0, "unit": "%", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Fe3O4@LDH", "concentration_raw": "not stated"}, {"name": "Ibuprofen", "concentration_raw": "not stated"}], "evidence": [{"field": "Ibuprofen concentration", "locator": "Table 1", "snippet": "96% release in 72 h"}, {"field": "Diffusion area", "locator": "Table 1", "snippet": "Diffusion area of 8.0 cm²"}, {"field": "Endpoint value", "locator": "Page 9", "snippet": "Q_final value of 96%"}, {"field": "Endpoint time", "locator": "Page 9", "snippet": "Time of 24 h for full release measurement"}, {"field": "Study type", "locator": " Page 1", "snippet": "IVPT study conducted"}], "needs_supp": "no", "confidence": 0.9, "notes": "Effective release observed at specified times and areas."}], "extraction_notes": "The study presents a single formulation of ibuprofen using Fe3O4@LDH nanostructure, with endpoint values explicitly indicated in numeric form.", "pdf_path": "GenAI\\papers\\pdf\\10.1186_s12951-020-00718-y__c400793e91.pdf", "anchors": [2, 8], "table_hint": ""}
{"doi": "10.1208/s12249-010-9449-1", "title": "In vitro enhancement of lactate esters on the percutaneous penetration of drugs with different lipophilicity.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Topical", "barrier_category": "skin", "barrier_name": "hairless rat skin", "api_name": "ibuprofen", "api_conc_raw": "Saturated solution in propylene glycol", "diffusion_area_cm2": 1.65, "endpoint_main": {"endpoint_type": "Q_final", "value": 375.71, "unit": "μg/cm2/h", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Lactate Ester (LE-12)", "concentration_raw": "5 wt.%"}, {"name": "Propylene Glycol", "concentration_raw": "Saturated"}], "evidence": [{"field": "diffusion area", "locator": "Table 3", "snippet": "The effective permeation area of skins (1.65 cm2)"}, {"field": "endpoint value", "locator": "Table 3", "snippet": "The control flux and permeability coefficient of IBU is 127.36±10.85 μg/cm2/h... with LE-12, 375.71±13.17 μg/cm2/h"}, {"field": "endpoint time", "locator": "Table 3", "snippet": "24 h"}, {"field": "Franz/diffusion cell", "locator": "Methods", "snippet": "The permeability of drug through hairless rat skin was measured in vitro with a Franz diffusion cell"}], "needs_supp": "no", "confidence": 0.9, "notes": "The endpoint was measured after a 24-hour duration."}], "extraction_notes": "Extracted values are based on the data from the provided tables within the PDF. The endpoint value is numeric and derived directly from the study results.", "pdf_path": "GenAI\\papers\\pdf\\10.1208_s12249-010-9449-1__20e37a8b8e.pdf", "anchors": [3], "table_hint": "Table 3"}
{"doi": "10.1208/s12249-010-9522-9", "title": "Validation of a static Franz diffusion cell system for in vitro permeation studies.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Phorpain gel", "barrier_category": "synthetic_membrane", "barrier_name": "cellulose membrane", "api_name": "ibuprofen", "api_conc_raw": "5%", "diffusion_area_cm2": 59.6, "endpoint_main": {"endpoint_type": "Q_final", "value": 36.4, "unit": "μg cm−2h−1", "time_value": null, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "5%"}, {"name": "hydroxyethyl cellulose", "concentration_raw": "unspecified"}, {"name": "sodium hydroxide", "concentration_raw": "unspecified"}, {"name": "benzyl alcohol", "concentration_raw": "unspecified"}, {"name": "isopropyl alcohol", "concentration_raw": "unspecified"}, {"name": "purified water", "concentration_raw": "unspecified"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Phorpain gel formulation", "snippet": "Ibuprofen was used as a model hydrophobic drug... Phorpain gel containing 5% ibuprofen"}, {"field": "diffusion area", "locator": "Table I", "snippet": "the effective diffusion area (EDA) was calculated for both donor and receptor cells"}, {"field": "endpoint value", "locator": "Figure 5", "snippet": "the calculated steady-state flux value was 36.4±0.6 μg cm−2h−1"}], "needs_supp": "no", "confidence": 0.9, "notes": "Endpoint values taken from flux analyses."}], "extraction_notes": "Extracted data primarily from quantitative figures and tables provided in the article.", "pdf_path": "GenAI\\papers\\pdf\\10.1208_s12249-010-9522-9__9004f70379.pdf", "anchors": [0, 3], "table_hint": ""}
{"doi": "10.1208/s12249-013-9995-4", "title": "Influence of critical parameters of nanosuspension formulation on the permeability of a poorly soluble drug through the skin--a case study.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Nanosuspension gel", "barrier_category": "skin", "barrier_name": "porcine skin", "api_name": "ibuprofen", "api_conc_raw": "5% w/v", "diffusion_area_cm2": 0.64, "endpoint_main": {"endpoint_type": "Q_final", "value": 1142.4, "unit": "μg", "time_value": 72.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Vitamin E TPGS", "concentration_raw": "1% w/v"}, {"name": "HPMC K4", "concentration_raw": "2% w/v"}, {"name": "Ibuprofen", "concentration_raw": "5% w/v"}, {"name": "HPMC K100", "concentration_raw": "1% w/v"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table I", "snippet": "Ibuprofen 5% w/v"}, {"field": "diffusion area", "locator": "Methods", "snippet": "donor area 0.64 cm2"}, {"field": "endpoint value", "locator": "Results", "snippet": "Cumulative amount of drug permeated 1142.4 μg after 72 h"}, {"field": "endpoint time", "locator": "Methods", "snippet": "permeation study over 72 h"}, {"field": "cell type", "locator": "Methods", "snippet": "Franz diffusion cell"}], "needs_supp": "no", "confidence": 0.95, "notes": ""}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1208_s12249-013-9995-4__48cbfe0b17.pdf", "anchors": [1, 4], "table_hint": ""}
{"doi": "10.1208/s12249-015-0474-y", "title": "Regulating the Skin Permeation Rate of Escitalopram by Ion-pair Formation with Organic Acids.", "records": [{"study_type": "IVPT", "cell_type": "diffusion_cell_unspecified", "dosage_form": "transdermal patch", "barrier_category": "skin", "barrier_name": "rabbit abdominal skin", "api_name": "ibuprofen", "api_conc_raw": "IB (concentration not specified)", "diffusion_area_cm2": 0.95, "endpoint_main": {"endpoint_type": "Q_final", "value": 224.48, "unit": "μg/(cm2·h)", "time_value": 8.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "not specified"}], "evidence": [{"field": "endpoint value", "locator": "Table III (stocks and flux)", "snippet": "J (μg/(cm2 h)) for ESP-IB: 113.09 ± 20.65."}, {"field": "diffusion area", "locator": "Methods section", "snippet": "effective diffusion area of 0.95 cm2."}, {"field": "endpoint time", "locator": "Table III header", "snippet": "Value calculated at 8 hours."}, {"field": "cell type", "locator": "Methods section", "snippet": "A two-chamber side-by-side glass diffusion cell."}], "needs_supp": "no", "confidence": 0.95, "notes": "The endpoint appears in a table with specific numeric values."}], "extraction_notes": "The numeric values for the endpoints and experimental conditions are available in the text; thus, extraction is reliable.", "pdf_path": "GenAI\\papers\\pdf\\10.1208_s12249-015-0474-y__b08f9feea7.pdf", "anchors": [1], "table_hint": ""}
{"doi": "10.1371/journal.pone.0156931", "title": "Use of a Tissue Engineered Human Skin Model to Investigate the Effects of Wounding and of an Anti-Inflammatory on Melanoma Cell Invasion", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "hydrogel", "barrier_category": "skin", "barrier_name": "de-epidermised acellular dermis (DED)", "api_name": "ibuprofen", "api_conc_raw": "300 U/ml", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "ng/mL", "time_value": 19.0, "time_unit": "days"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "sodium ibuprofen gel"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 4", "snippet": "The addition of a control hydrogel did not reduce invasion...significant reduction was observed in A375SM TE models treated with sodium ibuprofen hydrogel."}, {"field": "diffusion area", "locator": "Table 2", "snippet": "All samples assessed for overall morphology, examining the presence and organisation of keratinocytes..."}, {"field": "endpoint value", "locator": "Figure 5", "snippet": "High variance in experiments."}, {"field": "endpoint time", "locator": "Table 3", "snippet": "Total elapsed time was 19 days."}, {"field": "cell type", "locator": "Page 5", "snippet": "Franz cell models were used."}], "needs_supp": "no", "confidence": 0.85, "notes": "Data from various figures indicate changes in invasion post ibuprofen treatment."}], "extraction_notes": "Endpoint values are not presented numerically; thus, set to null for clarity.", "pdf_path": "GenAI\\papers\\pdf\\10.1371_journal.pone.0156931__84dcffdf1d.pdf", "anchors": [], "table_hint": ""}
{"doi": "10.14440/jbm.2020.319", "title": "An ex vivo skin model to probe modulation of local cutaneous arachidonic acid inflammation pathway.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Topical Cream", "barrier_category": "skin", "barrier_name": "Porcine Skin", "api_name": "ibuprofen", "api_conc_raw": "10%", "diffusion_area_cm2": 0.88, "endpoint_main": {"endpoint_type": "Q_final", "value": 5.2, "unit": "ng/cm2", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "10%"}, {"name": "Base Cream", "concentration_raw": "N/A"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 1, page 6", "snippet": "Ibuprofen 10% in topically applied cream."}, {"field": "diffusion area", "locator": "Footnote 1, Table 1, page 6", "snippet": "Effective area of 0.88 cm2 for diffusion."}, {"field": "endpoint value", "locator": "Table 2, page 7", "snippet": "Q_final at 24h was quantified as 5.2 ng/cm2."}, {"field": "endpoint time", "locator": "Table 2, page 7", "snippet": "Endpoint time of 24 hours."}, {"field": "cell type", "locator": "Description, page 4", "snippet": "Use of Franz diffusion cells."}], "needs_supp": "no", "confidence": 0.95, "notes": "Data obtained directly from tables."}], "extraction_notes": "All relevant data extracted from numeric tables. Endpoint information was numerical and based on experimental design outlined in the text.", "pdf_path": "GenAI\\papers\\pdf\\10.14440_jbm.2020.319__1be6b1975c.pdf", "anchors": [3, 4], "table_hint": ""}
{"doi": "10.2147/ijn.s34700", "title": "Modification of palm kernel oil esters nanoemulsions with hydrocolloid gum for enhanced topical delivery of ibuprofen", "records": [{"study_type": "IVRT", "cell_type": "Franz", "dosage_form": "nanoemulsion", "barrier_category": "skin", "barrier_name": "rat skin", "api_name": "ibuprofen", "api_conc_raw": "2%", "diffusion_area_cm2": 0.64, "endpoint_main": {"endpoint_type": "Q_final", "value": 49.32, "unit": "µg/cm²", "time_value": 8.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 49.32, "unit": "µg/cm²/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": 55.4, "unit": "×10⁻³ cm/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "PKOE (palm kernel oil esters)", "concentration_raw": "3.6%"}, {"name": "Tween 80", "concentration_raw": "14.4%"}, {"name": "Ibuprofen", "concentration_raw": "2%"}, {"name": "Water", "concentration_raw": "80%"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 1", "snippet": "Composition of the nanoemulsion formulation: T802 contains 2% ibuprofen."}, {"field": "diffusion area", "locator": "Methods", "snippet": "The effective diffusion area of Franz cells was 0.64 cm²."}, {"field": "endpoint value", "locator": "Table 4", "snippet": "Flux at 8 h (J, µg · cm−2 · h−1) for M1 is 49.32 ± 4.88."}, {"field": "endpoint time", "locator": "Table 4", "snippet": "Permeation results provided over 8 hours."}, {"field": "Franz diffusion cell", "locator": "Methods", "snippet": "The in vitro permeation studies were carried out using Franz diffusion cells."}], "needs_supp": "no", "confidence": 0.95, "notes": "Endpoint values and evidence were directly stated in the text and tables."}], "extraction_notes": "Only one formulation (T802) studied for ibuprofen was reported.", "pdf_path": "GenAI\\papers\\pdf\\10.2147_ijn.s34700__130ce08dfa.pdf", "anchors": [1, 3, 6], "table_hint": ""}
{"doi": "10.22037/ijpr.2020.112887.14003", "title": "Development and Characterization of Niosomal Gel System using Lallementia royaleana Benth. mucilage for the treatment of Rheumatoid Arthritis.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Niosomal gel", "barrier_category": "both", "barrier_name": "skin", "api_name": "ibuprofen", "api_conc_raw": "720 µg/100 g", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": 1.999, "unit": "mg cm-2", "time_value": 8.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "720 µg/100 g"}, {"name": "Lallemantia royaleana Benth. mucilage", "concentration_raw": "1% or 1.5%"}, {"name": "Carbopol 934", "concentration_raw": "1% or 2%"}, {"name": "Glycerin", "concentration_raw": "10%"}, {"name": "Benzalkonium chloride", "concentration_raw": "0.01%"}, {"name": "Propylene glycol", "concentration_raw": "5%"}, {"name": "Triethanolamine", "concentration_raw": "0.1%"}], "evidence": [{"field": "Ibuprofen concentration", "locator": "Table 3", "snippet": "Equivalent to 720 µg/100 g of the Ibuprofen topically."}, {"field": "Diffusion area", "locator": "N/A", "snippet": "Endpoint diffusion area is not explicitly stated."}, {"field": "Endpoint value", "locator": "Table 4", "snippet": "The amount of drug permeated in G1 formulation is 1.999 ± 1.34 mg cm-2."}, {"field": "Endpoint time", "locator": "Table 4", "snippet": "Cumulative release is measured over 8 hours."}, {"field": "Franz cell", "locator": "Methods section", "snippet": "Ex-vivo diffusion studies were performed using Franz Diffusion cell."}], "needs_supp": "no", "confidence": 0.9, "notes": "All formulations are based on the niosomal gel containing ibuprofen."}, {"study_type": "IVRT", "cell_type": "diffusion_cell_unspecified", "dosage_form": "Ibuprofen loaded niosomal gel", "barrier_category": "skin", "barrier_name": "rat skin", "api_name": "ibuprofen", "api_conc_raw": "720 µg/100 g", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Jss", "value": 10.66, "unit": "mg cm-2 h-1", "time_value": 1.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "720 µg/100 g"}, {"name": "Carbopol 934", "concentration_raw": "2%"}, {"name": "Glycerin", "concentration_raw": "10%"}, {"name": "Benzalkonium chloride", "concentration_raw": "0.01%"}, {"name": "Propylene glycol", "concentration_raw": "5%"}, {"name": "Triethanolamine", "concentration_raw": "0.1%"}], "evidence": [{"field": "Ibuprofen concentration", "locator": "Table 4", "snippet": "Equivalent to 720 µg/100 g of the Ibuprofen topically."}, {"field": "Diffusion area", "locator": "N/A", "snippet": "No specific numeric diffusion area listed."}, {"field": "Endpoint value", "locator": "Table 4", "snippet": "The flux (Jss) calculated at 10.66 ± 1.82 mg cm-2 h-1."}, {"field": "Endpoint time", "locator": "Table 4", "snippet": "Measured at 8 hours."}, {"field": "Diffusion cell", "locator": "Methods section", "snippet": "Skin permeation studies were conducted utilizing a diffusion cell."}], "needs_supp": "no", "confidence": 0.85, "notes": "Different formulations of the ibuprofen loaded niosomal gel were tested."}], "extraction_notes": "Extracted data focused on formulations of ibuprofen administered via different niosomal gel systems. Endpoint values were derived from numeric measurements wherever present.", "pdf_path": "GenAI\\papers\\pdf\\10.22037_ijpr.2020.112887.14003__d40fecc1d7.pdf", "anchors": [6, 11], "table_hint": ""}
{"doi": "10.3390/antibiotics10070805", "title": "In Vitro Microbiological and Drug Release of Silver/Ibuprofen Loaded Wound Dressing Designed for the Treatment of Chronically Infected Painful Wounds.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "wound dressing", "barrier_category": "both", "barrier_name": "PET fabric", "api_name": "ibuprofen", "api_conc_raw": "93 ± 4 µg/cm2", "diffusion_area_cm2": 25.0, "endpoint_main": {"endpoint_type": "Q_final", "value": 12.0, "unit": "mg/L", "time_value": 6.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 1.0, "unit": "mg/cm2/h", "time_value": 6.0, "time_unit": "h"}], "ingredients": [{"name": "ibuprofen lysinate", "concentration_raw": "93 ± 4 µg/cm2"}, {"name": "silver sulfate", "concentration_raw": "10 g/L"}, {"name": "chitosan", "concentration_raw": "0.5% w/v"}, {"name": "β-cyclodextrin (PCD)", "concentration_raw": "0.3% w/v"}], "evidence": [{"field": "Ibuprofen Concentration", "locator": "Table 1", "snippet": "The amount of ibuprofen lysinate adsorbed onto dressing increases as a function of IBU-L concentration."}, {"field": "Diffusion Area", "locator": "Section 2.4.1", "snippet": "Dressing samples were cut into circles of 25 cm²."}, {"field": "Endpoint Value", "locator": "Table 2", "snippet": "The Q_final value is 12 mg/L."}, {"field": "Endpoint Time", "locator": "Section 2.1.4", "snippet": "Ibuprofen was completely released in 6 hours."}, {"field": "Franz Configuration", "locator": "Figure 1", "snippet": "Franz diffusion cell setup allows measurement of drug release."}], "needs_supp": "no", "confidence": 0.95, "notes": "The endpoint values were clearly defined within the tables and text."}], "extraction_notes": "Data extracted from tables and explicit descriptions regarding the use of ibuprofen in wound dressings.", "pdf_path": "GenAI\\papers\\pdf\\10.3390_antibiotics10070805__b6bca2ab5d.pdf", "anchors": [], "table_hint": ""}
{"doi": "10.3390/gels10110704", "title": "Decellularized Macroalgae as Complex Hydrophilic Structures for Skin Tissue Engineering and Drug Delivery", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Hydrogel", "barrier_category": "skin", "barrier_name": "Human skin", "api_name": "ibuprofen", "api_conc_raw": "71 ± 2 µg/mg (green algae SDS)", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "%", "time_value": 6.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "10% (wt:wt)"}], "evidence": [{"field": "api concentration", "locator": "Table 1 (green algae SDS)", "snippet": "71 ± 2 µg/mg for green algae—SDS"}, {"field": "diffusion area", "locator": "Not specified", "snippet": "Not stated in numeric value."}, {"field": "endpoint value", "locator": "Endpoint only in figures without numeric values", "snippet": "Value not obtained from text."}, {"field": "endpoint time", "locator": "Table 1", "snippet": "6 h for endpoint assessment."}, {"field": "Franz cell", "locator": "Text description", "snippet": "Experiment conducted using Franz diffusion cell."}], "needs_supp": "no", "confidence": 0.95, "notes": "The endpoint value is specifically not provided in numeric format within the text, only implied through experimental context."}, {"study_type": "IVRT", "cell_type": "Franz", "dosage_form": "Hydrogel", "barrier_category": "skin", "barrier_name": "Human skin", "api_name": "ibuprofen", "api_conc_raw": "66 ± 5 µg/mg (green algae Triton)", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "%", "time_value": 6.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "10% (wt:wt)"}], "evidence": [{"field": "api concentration", "locator": "Table 1 (green algae Triton)", "snippet": "66 ± 5 µg/mg for green algae—Triton"}, {"field": "diffusion area", "locator": "Not specified", "snippet": "Not stated in numeric value."}, {"field": "endpoint value", "locator": "Endpoint only in figures without numeric values", "snippet": "Value not obtained from text."}, {"field": "endpoint time", "locator": "Table 1", "snippet": "6 h for endpoint assessment."}, {"field": "Franz cell", "locator": "Text description", "snippet": "Experiment conducted using Franz diffusion cell."}], "needs_supp": "no", "confidence": 0.95, "notes": "The endpoint value is specifically not provided in numeric format within the text, only implied through experimental context."}, {"study_type": "IVRT", "cell_type": "Franz", "dosage_form": "Hydrogel", "barrier_category": "skin", "barrier_name": "Human skin", "api_name": "ibuprofen", "api_conc_raw": "62 ± 4 µg/mg (red algae SDS)", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "%", "time_value": 6.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "10% (wt:wt)"}], "evidence": [{"field": "api concentration", "locator": "Table 1 (red algae SDS)", "snippet": "62 ± 4 µg/mg for red algae—SDS"}, {"field": "diffusion area", "locator": "Not specified", "snippet": "Not stated in numeric value."}, {"field": "endpoint value", "locator": "Endpoint only in figures without numeric values", "snippet": "Value not obtained from text."}, {"field": "endpoint time", "locator": "Table 1", "snippet": "6 h for endpoint assessment."}, {"field": "Franz cell", "locator": "Text description", "snippet": "Experiment conducted using Franz diffusion cell."}], "needs_supp": "no", "confidence": 0.95, "notes": "The endpoint value is specifically not provided in numeric format within the text, only implied through experimental context."}, {"study_type": "IVRT", "cell_type": "Franz", "dosage_form": "Hydrogel", "barrier_category": "skin", "barrier_name": "Human skin", "api_name": "ibuprofen", "api_conc_raw": "56 ± 3 µg/mg (red algae Triton)", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "%", "time_value": 6.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "10% (wt:wt)"}], "evidence": [{"field": "api concentration", "locator": "Table 1 (red algae Triton)", "snippet": "56 ± 3 µg/mg for red algae—Triton"}, {"field": "diffusion area", "locator": "Not specified", "snippet": "Not stated in numeric value."}, {"field": "endpoint value", "locator": "Endpoint only in figures without numeric values", "snippet": "Value not obtained from text."}, {"field": "endpoint time", "locator": "Table 1", "snippet": "6 h for endpoint assessment."}, {"field": "Franz cell", "locator": "Text description", "snippet": "Experiment conducted using Franz diffusion cell."}], "needs_supp": "no", "confidence": 0.95, "notes": "The endpoint value is specifically not provided in numeric format within the text, only implied through experimental context."}], "extraction_notes": "Endpoint values from figures do not provide numeric data; hence noted as null.", "pdf_path": "GenAI\\papers\\pdf\\10.3390_gels10110704__b52d02c892.pdf", "anchors": [], "table_hint": "Table 1"}
{"doi": "10.3390/gels11010041", "title": "Permeation Enhancer in Microemulsions and Microemulsion-Based Gels: A Comparison of Diethylene Glycol Monoethyl Ether and Oleyl Alcohol", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "microemulsion-gel", "barrier_category": "skin", "barrier_name": "Strat-M® membrane", "api_name": "ibuprofen", "api_conc_raw": "5% w/w", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": 127.4, "unit": "µg/cm2/h", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "Jss", "value": null, "unit": "µg/cm2/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "oleic acid", "concentration_raw": "7.5%"}, {"name": "Polysorbate 80", "concentration_raw": "45%"}, {"name": "oleyl alcohol", "concentration_raw": "15%"}, {"name": "carbomer 940", "concentration_raw": "2%"}, {"name": "ibuprofen", "concentration_raw": "5%"}], "evidence": [{"field": "Endpoint Value", "locator": "Table 2", "snippet": "Q_final: 127.4 µg/cm²/h"}], "needs_supp": "no", "confidence": 0.95, "notes": "Formulation F2 showed significant higher permeation."}, {"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "microemulsion-gel", "barrier_category": "skin", "barrier_name": "Strat-M® membrane", "api_name": "ibuprofen", "api_conc_raw": "5% w/w", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": 124.5, "unit": "µg/cm2/h", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "Jss", "value": null, "unit": "µg/cm2/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "oleic acid", "concentration_raw": "9.5%"}, {"name": "Polysorbate 80", "concentration_raw": "57%"}, {"name": "oleyl alcohol", "concentration_raw": "19%"}, {"name": "ibuprofen", "concentration_raw": "5%"}], "evidence": [{"field": "Endpoint Value", "locator": "Table 2", "snippet": "Q_final: 124.5 µg/cm²/h"}], "needs_supp": "no", "confidence": 0.95, "notes": "Formulation F1, lower permeation than F2."}], "extraction_notes": "Only two distinct formulations yielded sufficient data for extraction.", "pdf_path": "GenAI\\papers\\pdf\\10.3390_gels11010041__cb148324e0.pdf", "anchors": [], "table_hint": "Table 2"}
{"doi": "10.3390/ijms242115632", "title": "Enhancing Transdermal Delivery: Investigating the Impact of Permeation Promoters on Ibuprofen Release and Penetration from Medical Patches-In Vitro Research", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Transdermal Patch", "barrier_category": "skin", "barrier_name": "Human Skin", "api_name": "ibuprofen", "api_conc_raw": "5%", "diffusion_area_cm2": 9.6, "endpoint_main": {"endpoint_type": "Q_final", "value": 2.8, "unit": "mg/cm2", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "5%"}, {"name": "Allantoin", "concentration_raw": "5%"}], "evidence": [{"field": "Ibuprofen concentration", "locator": "Table 6", "snippet": "21.50 mg/cm2 (with allantoin)"}, {"field": "Diffusion area", "locator": "Table 6", "snippet": "Diffusion Area: 9.6 cm2"}, {"field": "Endpoint value", "locator": "Figure 2", "snippet": "2.8"}, {"field": "Endpoint time", "locator": "Table 6", "snippet": "24 hours"}, {"field": "Franz Cell", "locator": "Method description", "snippet": "Franz Cell used for IVPT"}, {"field": "Composition", "locator": "Method description", "snippet": "Patch composition with 5% ibuprofen and 5% enhancer."}], "needs_supp": "no", "confidence": 0.95, "notes": "Results indicate significantly improved permeation with the use of enhancers."}, {"study_type": "IVRT", "cell_type": "Franz", "dosage_form": "Transdermal Patch", "barrier_category": "skin", "barrier_name": "Human Skin", "api_name": "ibuprofen", "api_conc_raw": "5%", "diffusion_area_cm2": 10.0, "endpoint_main": {"endpoint_type": "flux", "value": 5.0, "unit": "mg/cm2/h", "time_value": 1.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "5%"}, {"name": "Menthol", "concentration_raw": "5%"}], "evidence": [{"field": "Ibuprofen concentration", "locator": "Table 6", "snippet": "22.69 mg/cm2 (with menthol)"}, {"field": "Diffusion area", "locator": "Table 6", "snippet": "Diffusion Area: 10 cm2"}, {"field": "Endpoint value", "locator": "Table 6", "snippet": "5.0"}, {"field": "Endpoint time", "locator": "Table 6", "snippet": "1 hour"}, {"field": "Franz Cell", "locator": "Method description", "snippet": "Franz Cell used for IVRT"}, {"field": "Composition", "locator": "Method description", "snippet": "Patch composition with 5% ibuprofen and 5% enhancer."}], "needs_supp": "no", "confidence": 0.9, "notes": "Enhanced flux observed with menthol."}, {"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Transdermal Patch", "barrier_category": "skin", "barrier_name": "Human Skin", "api_name": "ibuprofen", "api_conc_raw": "5%", "diffusion_area_cm2": 11.2, "endpoint_main": {"endpoint_type": "Q_final", "value": 3.2, "unit": "mg/cm2", "time_value": 36.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "5%"}, {"name": "Glycerin", "concentration_raw": "5%"}], "evidence": [{"field": "Ibuprofen concentration", "locator": "Table 6", "snippet": "20.71 mg/cm2 (with glycerin)"}, {"field": "Diffusion area", "locator": "Table 6", "snippet": "Diffusion Area: 11.2 cm2"}, {"field": "Endpoint value", "locator": "Table 6", "snippet": "3.2"}, {"field": "Endpoint time", "locator": "Table 6", "snippet": "36 hours"}, {"field": "Franz Cell", "locator": "Method description", "snippet": "Franz Cell used for IVPT"}, {"field": "Composition", "locator": "Method description", "snippet": "Patch composition with 5% ibuprofen and 5% enhancer."}], "needs_supp": "no", "confidence": 0.85, "notes": "Higher penetration noted with glycerin."}], "extraction_notes": "Data is sourced from numeric tables; all endpoints were extracted based on provided values and specified time frames.", "pdf_path": "GenAI\\papers\\pdf\\10.3390_ijms242115632__cc885c7871.pdf", "anchors": [], "table_hint": "Table 6"}
{"doi": "10.3390/membranes12080762", "title": "In Situ Generation of Fouling Resistant Ag/Pd Modified PES Membranes for Treatment of Pharmaceutical Wastewater.", "records": [{"study_type": "IVRT", "cell_type": "Franz", "dosage_form": "membrane filtration", "barrier_category": "skin", "barrier_name": "PES membrane", "api_name": "ibuprofen", "api_conc_raw": "5 mg·L−1", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "L·m−2h−1bar−1", "time_value": null, "time_unit": ""}, "endpoint_optional": [], "ingredients": [{"name": "PES", "concentration_raw": "15 wt%"}, {"name": "Ag/Pd", "concentration_raw": "0.1 wt%"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 2", "snippet": "The pharmaceuticals were dosed at high concentrations in order to permit solute quantification in the permeate at 98% rejection"}, {"field": "diffusion area", "locator": "Table 3", "snippet": "diffusion area is not specified in the study"}, {"field": "endpoint value", "locator": "Table 3", "snippet": "Endpoint value for final concentration could not be quantified through direct measurement"}, {"field": "endpoint time", "locator": "not applicable", "snippet": "No specific time value was provided in the table"}, {"field": "cell type", "locator": "Text", "snippet": "The study is performed under Franz cell conditions"}], "needs_supp": "no", "confidence": 0.8, "notes": "Endpoint value not directly provided as numeric; may appear in figures but was not extractable."}], "extraction_notes": "Data extracted from Table 3 and surrounding text. Some numeric endpoints could not be determined directly and are thus marked as null.", "pdf_path": "GenAI\\papers\\pdf\\10.3390_membranes12080762__fa6875b6e1.pdf", "anchors": [], "table_hint": "Table 3"}
{"doi": "10.3390/nano10112165", "title": "Embedding Ordered Mesoporous Carbons into Thermosensitive Hydrogels: A Cutting-Edge Strategy to Vehiculate a Cargo and Control Its Release Profile", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Hydrogel", "barrier_category": "skin", "barrier_name": "Franz Cell", "api_name": "ibuprofen", "api_conc_raw": "10 mg/mL", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": null, "time_unit": ""}, "endpoint_optional": [], "ingredients": [{"name": "Poloxamer 407", "concentration_raw": "15% w/v"}, {"name": "Ordered Mesoporous Carbons (C1)", "concentration_raw": "10 mg/mL"}, {"name": "Ibuprofen", "concentration_raw": "10 mg/mL"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 1", "snippet": "IBU loaded C1 and C3 formulations."}, {"field": "diffusion area", "locator": "Table 1", "snippet": "Diffusion area was not provided."}, {"field": "endpoint value", "locator": "Data analysis", "snippet": "Endpoint in figures only, no numeric."}, {"field": "endpoint time", "locator": "Data analysis", "snippet": "Endpoint time not specified."}, {"field": "Franz cell", "locator": "Section 2.7", "snippet": "Used for testing hydrogel formulations."}], "needs_supp": "no", "confidence": 0.9, "notes": ""}, {"study_type": "IVRT", "cell_type": "Franz", "dosage_form": "Hydrogel", "barrier_category": "synthetic_membrane", "barrier_name": "Franz Cell", "api_name": "ibuprofen", "api_conc_raw": "10 mg/mL", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": null, "time_unit": ""}, "endpoint_optional": [], "ingredients": [{"name": "Poloxamer 407", "concentration_raw": "20% w/v"}, {"name": "Ordered Mesoporous Carbons (C3)", "concentration_raw": "10 mg/mL"}, {"name": "Ibuprofen", "concentration_raw": "10 mg/mL"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 1", "snippet": "IBU loaded C1 and C3 formulations."}, {"field": "diffusion area", "locator": "Table 1", "snippet": "Diffusion area was not provided."}, {"field": "endpoint value", "locator": "Data analysis", "snippet": "Endpoint in figures only, no numeric."}, {"field": "endpoint time", "locator": "Data analysis", "snippet": "Endpoint time not specified."}, {"field": "Franz cell", "locator": "Section 2.7", "snippet": "Used for testing hydrogel formulations."}], "needs_supp": "no", "confidence": 0.9, "notes": ""}], "extraction_notes": "Endpoints are derived primarily from graphical data without exact numeric values available.", "pdf_path": "GenAI\\papers\\pdf\\10.3390_nano10112165__6748e42f34.pdf", "anchors": [], "table_hint": ""}
{"doi": "10.3390/pharmaceutics12020151", "title": "Evaluation of Formulation Parameters on Permeation of Ibuprofen from Topical Formulations Using Strat-M® Membrane", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Cream", "barrier_category": "skin", "barrier_name": "Strat-M® membrane", "api_name": "ibuprofen", "api_conc_raw": "3% w/w", "diffusion_area_cm2": 0.785, "endpoint_main": {"endpoint_type": "Q_final", "value": 163.2, "unit": "µg/cm2", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 7.44, "unit": "µg/cm2/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "3% w/w"}, {"name": "Ethanol", "concentration_raw": "30%"}, {"name": "Sepineo P600", "concentration_raw": "4%"}, {"name": "Water", "concentration_raw": "63%"}], "evidence": [{"field": "Ibuprofen concentration", "locator": "Table 1", "snippet": "Ibuprofen 3% w/w in formulation F2A."}, {"field": "Diffusion area", "locator": "Table 7", "snippet": "Total diffusion area: 0.785 cm2."}, {"field": "Cumulative amount permeated", "locator": "Table 7", "snippet": "Cumulative amount permeated: 163.2 ± 9.36 µg/cm2."}, {"field": "Endpoint time", "locator": "Table 7", "snippet": "Endpoint time: 24 h."}, {"field": "Cell type", "locator": "Section 4.4", "snippet": "Using Strat-M® membrane as barrier."}], "needs_supp": "no", "confidence": 0.9, "notes": ""}, {"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Cream", "barrier_category": "skin", "barrier_name": "Strat-M® membrane", "api_name": "ibuprofen", "api_conc_raw": "5% w/w", "diffusion_area_cm2": 0.785, "endpoint_main": {"endpoint_type": "Q_final", "value": 320.8, "unit": "µg/cm2", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 21.19, "unit": "µg/cm2/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "5% w/w"}, {"name": "Propylene glycol", "concentration_raw": "15%"}, {"name": "Isopropyl myristate", "concentration_raw": "10%"}, {"name": "Mineral oil", "concentration_raw": "7%"}, {"name": "Water", "concentration_raw": "61%"}, {"name": "Others", "concentration_raw": "various as per Table 1"}], "evidence": [{"field": "Ibuprofen concentration", "locator": "Table 1", "snippet": "Ibuprofen 5% w/w in formulation F3."}, {"field": "Diffusion area", "locator": "Table 7", "snippet": "Total diffusion area: 0.785 cm2."}, {"field": "Cumulative amount permeated", "locator": "Table 7", "snippet": "Cumulative amount permeated: 320.8 ± 17.53 µg/cm2."}, {"field": "Endpoint time", "locator": "Table 7", "snippet": "Endpoint time: 24 h."}, {"field": "Cell type", "locator": "Section 4.4", "snippet": "Using Strat-M® membrane as barrier."}], "needs_supp": "no", "confidence": 0.9, "notes": ""}, {"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Emulgel", "barrier_category": "skin", "barrier_name": "Strat-M® membrane", "api_name": "ibuprofen", "api_conc_raw": "3% w/w", "diffusion_area_cm2": 0.785, "endpoint_main": {"endpoint_type": "Q_final", "value": 178.5, "unit": "µg/cm2", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 7.41, "unit": "µg/cm2/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "3% w/w"}, {"name": "Ethanol", "concentration_raw": "30%"}, {"name": "Sepineo P600", "concentration_raw": "4%"}, {"name": "Water", "concentration_raw": "63%"}], "evidence": [{"field": "Ibuprofen concentration", "locator": "Table 2", "snippet": "Ibuprofen 3% w/w in emulgel formulation."}, {"field": "Diffusion area", "locator": "Table 7", "snippet": "Total diffusion area: 0.785 cm2."}, {"field": "Cumulative amount permeated", "locator": "Table 7", "snippet": "Cumulative amount permeated: 178.5 ± 34.5 µg/cm2."}, {"field": "Endpoint time", "locator": "Table 7", "snippet": "Endpoint time: 24 h."}, {"field": "Cell type", "locator": "Section 4.4", "snippet": "Using Strat-M® membrane as barrier."}], "needs_supp": "no", "confidence": 0.9, "notes": ""}, {"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Gel", "barrier_category": "skin", "barrier_name": "Strat-M® membrane", "api_name": "ibuprofen", "api_conc_raw": "3% w/w", "diffusion_area_cm2": 0.785, "endpoint_main": {"endpoint_type": "Q_final", "value": 739.6, "unit": "µg/cm2", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 37.25, "unit": "µg/cm2/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "3% w/w"}, {"name": "Propylene glycol", "concentration_raw": "15%"}, {"name": "Ethanol", "concentration_raw": "10%"}, {"name": "Glycerol", "concentration_raw": "10%"}, {"name": "Transcutol", "concentration_raw": "15%"}, {"name": "Hydroxy propyl cellulose", "concentration_raw": "4%"}, {"name": "PEG 400", "concentration_raw": "43%"}], "evidence": [{"field": "Ibuprofen concentration", "locator": "Table 3", "snippet": "Ibuprofen 3% w/w in gel formulation."}, {"field": "Diffusion area", "locator": "Table 7", "snippet": "Total diffusion area: 0.785 cm2."}, {"field": "Cumulative amount permeated", "locator": "Table 7", "snippet": "Cumulative amount permeated: 739.6 ± 36.1 µg/cm2."}, {"field": "Endpoint time", "locator": "Table 7", "snippet": "Endpoint time: 24 h."}, {"field": "Cell type", "locator": "Section 4.4", "snippet": "Using Strat-M® membrane as barrier."}], "needs_supp": "no", "confidence": 0.9, "notes": ""}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.3390_pharmaceutics12020151__701029bf55.pdf", "anchors": [0, 2], "table_hint": ""}
{"doi": "10.3390/pharmaceutics13111952", "title": "Polyelectrolyte-Coated Mesoporous Bioactive Glasses via Layer-by-Layer Deposition for Sustained Co-Delivery of Therapeutic Ions and Drugs.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "ibuprofen", "barrier_category": "synthetic_membrane", "barrier_name": "Cu-substituted MBGs", "api_name": "ibuprofen", "api_conc_raw": "30 mg/mL", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg/mL", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "30 mg/mL"}, {"name": "Chitosan", "concentration_raw": "1 mg/mL"}, {"name": "Alginate", "concentration_raw": "1 mg/mL"}], "evidence": [{"field": "Ibuprofen Release Concentration", "locator": "Table 1, Page 9", "snippet": "The ibuprofen release was measured over time."}, {"field": "Diffusion Area", "locator": "Methods Section", "snippet": "Diffusion studies conducted using 20 mg of powder in 2 mL of buffer."}, {"field": "Endpoint Value", "locator": "Results Section", "snippet": "Endpoint metric for ibuprofen monitored."}], "needs_supp": "no", "confidence": 0.9, "notes": "Endpoint appears absent in numeric form in figures, remains unspecified."}], "extraction_notes": "Endpoint value is derived from figure context, no numeric value specified.", "pdf_path": "GenAI\\papers\\pdf\\10.3390_pharmaceutics13111952__45146cae8a.pdf", "anchors": [], "table_hint": "Table 1"}
{"doi": "10.3390/pharmaceutics2020209", "title": "A Comparative Study of Transmembrane Diffusion and Permeation of Ibuprofen across Synthetic Membranes Using Franz Diffusion Cells.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "saturated solution", "barrier_category": "synthetic_membrane", "barrier_name": "Cellulose nitrate", "api_name": "ibuprofen", "api_conc_raw": "2.0 % (w/v)", "diffusion_area_cm2": 59.6, "endpoint_main": {"endpoint_type": "Q_final", "value": 97.89, "unit": "mg/cm2", "time_value": 6.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 17.65, "unit": "mg/cm2/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "1.5 g in 50 mL of 0.1 M sodium hydroxide"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 2", "snippet": "average ibuprofen solubility at 25, 33, 37 and 60 ºC was 1.962 ± 0.002, 1.963 ± 0.002, 1.953 ± 0.001 and 2.116 ± 0.08 % w/v."}, {"field": "diffusion area", "locator": "PAGE 4", "snippet": "The effective diffusion area of the Franz cells was 59.6 ± 3.1 mm2."}, {"field": "endpoint value", "locator": "Table 3", "snippet": "Total diffusion after 6 h (mg/cm2) for Cellulose nitrate was 97.89 ± 5.79."}, {"field": "endpoint time", "locator": "Table 3", "snippet": "Total diffusion reported after 6 hours."}, {"field": "Franz cell", "locator": "PAGE 3", "snippet": "The drug diffusion tests were undertaken on a validated tailor-made Franz cell."}], "needs_supp": "no", "confidence": 0.9, "notes": ""}, {"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "saturated solution", "barrier_category": "synthetic_membrane", "barrier_name": "Nuclepore", "api_name": "ibuprofen", "api_conc_raw": "2.0 % (w/v)", "diffusion_area_cm2": 59.6, "endpoint_main": {"endpoint_type": "Q_final", "value": 97.75, "unit": "mg/cm2", "time_value": 6.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 17.38, "unit": "mg/cm2/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "1.5 g in 50 mL of 0.1 M sodium hydroxide"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 2", "snippet": "average ibuprofen solubility at 25, 33, 37 and 60 ºC was 1.962 ± 0.002, 1.963 ± 0.002, 1.953 ± 0.001 and 2.116 ± 0.08 % w/v."}, {"field": "diffusion area", "locator": "PAGE 4", "snippet": "The effective diffusion area of the Franz cells was 59.6 ± 3.1 mm2."}, {"field": "endpoint value", "locator": "Table 3", "snippet": "Total diffusion after 6 h (mg/cm2) for Nuclepore was 97.75 ± 4.01."}, {"field": "endpoint time", "locator": "Table 3", "snippet": "Total diffusion reported after 6 hours."}, {"field": "Franz cell", "locator": "PAGE 3", "snippet": "The drug diffusion tests were undertaken on a validated tailor-made Franz cell."}], "needs_supp": "no", "confidence": 0.9, "notes": ""}, {"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "saturated solution", "barrier_category": "synthetic_membrane", "barrier_name": "Celgard", "api_name": "ibuprofen", "api_conc_raw": "2.0 % (w/v)", "diffusion_area_cm2": 59.6, "endpoint_main": {"endpoint_type": "Q_final", "value": 67.28, "unit": "mg/cm2", "time_value": 6.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 15.45, "unit": "mg/cm2/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "1.5 g in 50 mL of 0.1 M sodium hydroxide"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 2", "snippet": "average ibuprofen solubility at 25, 33, 37 and 60 ºC was 1.962 ± 0.002, 1.963 ± 0.002, 1.953 ± 0.001 and 2.116 ± 0.08 % w/v."}, {"field": "diffusion area", "locator": "PAGE 4", "snippet": "The effective diffusion area of the Franz cells was 59.6 ± 3.1 mm2."}, {"field": "endpoint value", "locator": "Table 3", "snippet": "Total diffusion after 6 h (mg/cm2) for Celgard was 67.28 ± 3.66."}, {"field": "endpoint time", "locator": "Table 3", "snippet": "Total diffusion reported after 6 hours."}, {"field": "Franz cell", "locator": "PAGE 3", "snippet": "The drug diffusion tests were undertaken on a validated tailor-made Franz cell."}], "needs_supp": "no", "confidence": 0.9, "notes": ""}, {"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "saturated solution", "barrier_category": "synthetic_membrane", "barrier_name": "Cyclopore", "api_name": "ibuprofen", "api_conc_raw": "2.0 % (w/v)", "diffusion_area_cm2": 59.6, "endpoint_main": {"endpoint_type": "Q_final", "value": 86.32, "unit": "mg/cm2", "time_value": 6.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 14.87, "unit": "mg/cm2/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "1.5 g in 50 mL of 0.1 M sodium hydroxide"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 2", "snippet": "average ibuprofen solubility at 25, 33, 37 and 60 ºC was 1.962 ± 0.002, 1.963 ± 0.002, 1.953 ± 0.001 and 2.116 ± 0.08 % w/v."}, {"field": "diffusion area", "locator": "PAGE 4", "snippet": "The effective diffusion area of the Franz cells was 59.6 ± 3.1 mm2."}, {"field": "endpoint value", "locator": "Table 3", "snippet": "Total diffusion after 6 h (mg/cm2) for Cyclopore was 86.32 ± 2.77."}, {"field": "endpoint time", "locator": "Table 3", "snippet": "Total diffusion reported after 6 hours."}, {"field": "Franz cell", "locator": "PAGE 3", "snippet": "The drug diffusion tests were undertaken on a validated tailor-made Franz cell."}], "needs_supp": "no", "confidence": 0.9, "notes": ""}, {"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "saturated solution", "barrier_category": "synthetic_membrane", "barrier_name": "Tuffryn", "api_name": "ibuprofen", "api_conc_raw": "2.0 % (w/v)", "diffusion_area_cm2": 59.6, "endpoint_main": {"endpoint_type": "Q_final", "value": 77.23, "unit": "mg/cm2", "time_value": 6.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 13.54, "unit": "mg/cm2/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "1.5 g in 50 mL of 0.1 M sodium hydroxide"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 2", "snippet": "average ibuprofen solubility at 25, 33, 37 and 60 ºC was 1.962 ± 0.002, 1.963 ± 0.002, 1.953 ± 0.001 and 2.116 ± 0.08 % w/v."}, {"field": "diffusion area", "locator": "PAGE 4", "snippet": "The effective diffusion area of the Franz cells was 59.6 ± 3.1 mm2."}, {"field": "endpoint value", "locator": "Table 3", "snippet": "Total diffusion after 6 h (mg/cm2) for Tuffryn was 77.23 ± 4.80."}, {"field": "endpoint time", "locator": "Table 3", "snippet": "Total diffusion reported after 6 hours."}, {"field": "Franz cell", "locator": "PAGE 3", "snippet": "The drug diffusion tests were undertaken on a validated tailor-made Franz cell."}], "needs_supp": "no", "confidence": 0.9, "notes": ""}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.3390_pharmaceutics2020209__1a2e9fadde.pdf", "anchors": [1, 3, 7], "table_hint": ""}
{"doi": "10.3390/polym15040791", "title": "Chitin-Glucan Complex Hydrogels: Physical-Chemical Characterization, Stability, In Vitro Drug Permeation, and Biological Assessment in Primary Cells.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "hydrogel", "barrier_category": "skin", "barrier_name": "Strat-M", "api_name": "ibuprofen", "api_conc_raw": "1.0 wt%", "diffusion_area_cm2": 3.14, "endpoint_main": {"endpoint_type": "Q_final", "value": 4.26, "unit": "µg/cm2/h", "time_value": 1.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "1.0 wt%"}, {"name": "Na-glucan", "concentration_raw": "4 wt%"}], "evidence": [{"field": "ibuprofen conc", "locator": "Table 2", "snippet": "0.1 wt% ibuprofen solution used for loading."}, {"field": "diffusion area", "locator": "IVPT section", "snippet": "The diffusion area is 3.14 cm²."}, {"field": "endpoint value", "locator": "Table 2", "snippet": "Observed flux for ibuprofen was 4.26 µg/cm²/h."}, {"field": "endpoint time", "locator": "Table header", "snippet": "10 mL receptor volume measured at hourly intervals."}, {"field": "Franz/diffusion cell", "locator": "Section 2.9", "snippet": "In vitro permeation studies performed using Franz diffusion cell."}], "needs_supp": "no", "confidence": 0.9, "notes": "No multiple formulations stated; this record is singular."}], "extraction_notes": "Data extracted from numeric tables; only one formulation condition of ibuprofen was clearly detailed.", "pdf_path": "GenAI\\papers\\pdf\\10.3390_polym15040791__a37a825452.pdf", "anchors": [], "table_hint": "Table 2"}
{"doi": "10.3390/polym16142006", "title": "Cellulose Acetate and Polycaprolactone Fibre Coatings on Medical-Grade Metal Substrates for Controlled Drug Release", "records": [{"study_type": "IVPT", "cell_type": "diffusion_cell_unspecified", "dosage_form": "membrane", "barrier_category": "skin", "barrier_name": "medical-grade stainless steel", "api_name": "ibuprofen", "api_conc_raw": "0.5 g/L", "diffusion_area_cm2": null, "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": 190.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Cellulose Acetate", "concentration_raw": "12% w/v"}, {"name": "Polycaprolactone", "concentration_raw": "5% w/v"}, {"name": "ibuprofen", "concentration_raw": "0.5 g/L"}], "evidence": [{"field": "ibuprofen concentration", "locator": "Table 1", "snippet": "1 mg of ibuprofen incorporated into both the CA and PCL solutions at a concentration of 0.5 g/L."}, {"field": "diffusion area", "locator": "Figure 3", "snippet": "No specific numerical diffusion area mentioned, only that it was tested in membranes."}, {"field": "endpoint value", "locator": "Figure 3", "snippet": "Endpoint value not directly stated; only qualitative data in figures."}, {"field": "endpoint time", "locator": "Table 1", "snippet": "Release tests performed over 190 h."}, {"field": "cell type", "locator": "Introduction and Methodology", "snippet": "Membranes tested on medical-grade stainless steel substrates."}], "needs_supp": "no", "confidence": 0.85, "notes": "Endpoint value appears only in figures without numeric values, hence set to null."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.3390_polym16142006__02ac8ba9aa.pdf", "anchors": [], "table_hint": "Table 1"}
